Cerebral aneurysm, nonruptured

I9_ANEURYSM

brain aneurysm: A congenital or acquired aneurysm within the cranium.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I67.1 Hospital discharge: ICD-9 — 4373 Cause of death: ICD-10 — I67.1 Cause of death: ICD-9 — 4373 2 out of 7 registries used, show all original rules.	4085
4. Check minimum number of events None	4085
5. Include endpoints None	4085
6. Filter based on genotype QC (FinnGen only)	3646

Control definitions (FinnGen only)

Control exclude: I9_CEREBVASC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I67
Name in latin: Aneurysma encephali non ruptum

NAME	I9_ANEURYSM
CONTROL_EXCLUDE	I9_CEREBVASC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I671
HD_ICD_9	4373
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I671
COD_ICD_9	4373
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cerebral aneurysm, nonruptured based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17142	10253	6792
Only index persons	15532	9499	6033
Unadjusted period prevalence (%)
Whole population	0.25	0.29	0.19
Only index persons	0.30	0.35	0.23
Median age at first event (years)
Whole population	59.51	60.10	58.55
Only index persons	58.88	59.32	58.18

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3646	2354	1292
Unadjusted period prevalence (%)	0.75	0.84	0.59
Median age at first event (years)	58.70	58.27	59.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3735: Matched controls
37350

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

+∞

313.0

296

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

1887.6

307.7

331

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

112.0

307.7

513

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

152.1

307.7

590

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.9

307.7

791

1634

PA2AD

NOMESCO Finland

CT angiography of brain

47.1

307.7

263

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

108.9

307.7

355

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

527.7

307.7

617

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

307.7

1223

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

2081.2

307.7

357

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4503599627370496.0

307.7

3609

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

81.1

307.7

640

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

643.1

307.7

846

AA1AD

NOMESCO Finland

CT of head and brain

5.8

307.7

2010

6237

B01AC04

ATC

clopidogrel; oral

4.2

291.5

956

2803

K90

ICPC

Stroke/cerebrovascular accident

28.3

282.1

191

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.1

277.2

663

1512

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

484.0

274.6

271

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

2526.8

258.2

247

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

9.4

252.5

312

357

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

45.8

232.4

137

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

599.0

230.2

226

R51.80

ICD-10 Finland

Headache

3.5

225.1

971

3378

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

8.2

217.7

302

398

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

+∞

212.6

202

PA2MT

NOMESCO Finland

Endovascular closure of very extensive brain aneurysm

+∞

209.4

199

AAF00

NOMESCO Finland

Ventriculostomy

54.9

206.2

117

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

245.9

204.9

209

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

107.0

202.1

104

PA2AG

NOMESCO Finland

Restrected MRI examination of vessels in the head with high intensity magnet

78.7

200.2

107

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

2068.4

192.3

185

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

4.7

184.0

460

1073

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.2

180.5

926

3532

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

6.8

180.4

293

459

AAL00

NOMESCO Finland

Endovascular occlusion of intracranial aneurysm

+∞

178.6

170

AA5PD

NOMESCO Finland

CT examination of brain pefusion

38.7

177.4

109

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

13.7

177.4

167

127

4373A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured

+∞

169.0

161

XA800

NOMESCO Finland

Neuropsychological investigation

6.2

157.6

281

483

K91

ICPC

Cerebrovascular disease

25.2

156.4

110

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

779.6

153.4

150

2161

FHL

Neck ligation, big brain

+∞

144.7

138

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

31.4

141.2

WX882

NOMESCO Finland

High dependency care

7.0

136.4

215

325

N03AB02

ATC

phenytoin; systemic

14.1

134.3

124

AA9CW, ,

NOMESCO Finland

233.3

131.8

135

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

+∞

128.9

123

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

+∞

128.9

123

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

47.8

128.4

ZXM40

NOMESCO Finland

Use of fluorescent substance

53.3

119.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

118.5

802

3472

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1174.6

117.4

114

PA6AD

NOMESCO Finland

CT of neck arteries

5.6

114.9

226

425

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.5

114.7

293

689

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

5.4

114.2

233

453

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

18.1

111.4

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

+∞

106.8

102

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

51.7

106.1

N03AX14

ATC

levetiracetam; systemic

6.2

105.9

187

317

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.1

101.0

467

1638

R42

ICD-10 Finland

Dizziness and giddiness

2.3

99.4

1066

5627

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

99.3

780

3596

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

973.4

97.5

R4150

NOMESCO Finland

Neuropsychological rehabilitation

22.6

97.0

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

115.3

93.4

101

PA7BD

NOMESCO Finland

CT angiography of neck and brain

9.2

93.4

114

127

H53.4

ICD-10 Finland

Visual field defects

7.5

92.5

135

187

G91.0

ICD-10 Finland

Communicating hydrocephalus

21.3

89.4

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

9.4

88.9

107

117

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

233.1

88.9

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

+∞

87.8

G44.2

ICD-10 Finland

Tension-type headache

2.5

87.8

684

3126

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

5.1

87.5

188

382

I10

ICD-10 Finland

Essential (primary) hypertension

2.0

87.2

2545

19084

I72.0

ICD-10 Finland

Aneurysm and dissection of carotid artery

48.6

82.3

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

6.4

81.0

137

222

N18

ICPC

Paralysis/weakness

8.0

77.9

107

138

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

18.5

77.8

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

+∞

74.2

XCK00

NOMESCO Finland

Perimetry

3.1

73.8

327

1112

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

11.4

72.7

205

Kela drug reimbursment

Chronic hypertension

2.0

71.8

1067

6248

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

37.1

70.7

I63.8

ICD-10 Finland

Other cerebral infarction

353.8

69.8

Z2445

NOMESCO Finland

Psychologist

4.4

69.6

177

413

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.0

69.1

326

1148

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

67.0

1923

13806

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

8.9

65.7

N03AF02

ATC

oxcarbazepine; oral

4.3

65.6

173

415

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

64.1

1065

6436

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

17.6

63.6

H53.1

ICD-10 Finland

Subjective visual disturbances

2.7

63.6

359

1392

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

62.9

311

1123

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.1

61.9

109

184

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

61.7

1427

9538

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

+∞

61.6

H53.2

ICD-10 Finland

Diplopia

3.9

61.0

189

510

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

5.1

60.9

131

266

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

210.1

60.2

C08CA01

ATC

amlodipine; oral

1.8

57.4

1552

10790

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

57.4

I60.6

ICD-10 Finland

Subarachnoid haemorrhage from other intracranial arteries

+∞

56.4

C10AA05

ATC

atorvastatin; oral

1.7

56.0

1671

11918

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.3

55.4

214

668

I60.4

ICD-10 Finland

Subarachnoid haemorrhage from basilar artery

+∞

55.3

XX4AW, ,

NOMESCO Finland

119.9

54.9

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

53.8

562

2861

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

52.5

329

1341

Z82.3

ICD-10 Finland

Family history of stroke

20.7

51.4

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.6

51.1

176

510

ZXD05

NOMESCO Finland

Urgent procedure

1.8

51.1

1097

7088

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

5.0

50.4

110

226

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

12.7

50.4

I67.0

ICD-10 Finland

Dissection of cerebral arteries, nonruptured

+∞

48.0

ZXD35

NOMESCO Finland

Usual procedure

3.6

47.9

163

469

N03AF01

ATC

carbamazepine; oral, rectal

2.9

47.8

234

838

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.8

47.8

150

408

WX892

NOMESCO Finland

Monitored bed care

2.5

47.4

309

1282

R51

ICD-10 Finland

Headache

2.8

46.0

251

953

TAB00

NOMESCO Finland

Lumbar puncture

3.0

45.6

210

727

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.6

45.1

107

236

N02BE01

ATC

paracetamol; systemic, rectal

2.3

44.5

3412

30721

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

43.8

C07AB07

ATC

bisoprolol; oral

1.6

42.5

1827

13966

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

+∞

41.7

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

41.1

410

2039

N03AG01

ATC

valproic acid; systemic, rectal

2.6

39.6

244

984

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

38.6

246

1008

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

7.3

38.1

B01AC07

ATC

dipyridamole; systemic

3.7

38.1

121

332

315

Kela drug reimbursment

Clopidogrel

9.0

38.1

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

10.1

38.0

R4120

NOMESCO Finland

Occupational therapy

2.5

37.7

249

1038

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.6

36.7

124

355

G81.9

ICD-10 Finland

Hemiplegia, unspecified

7.0

35.6

N01

ICPC

Headache

2.0

35.5

398

2062

C07AB02

ATC

metoprolol; systemic

1.7

35.3

719

4509

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

5.2

35.2

140

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

34.5

357

1795

C10AA01

ATC

simvastatin; oral

1.5

34.4

1476

11102

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.5

33.4

226

952

B01AA03

ATC

warfarin; systemic

1.8

33.3

594

3581

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

117.8

32.7

R1260

NOMESCO Finland

Evaluation of communicative skills

5.2

32.5

131

N07BA03

ATC

varenicline; oral

2.5

32.2

212

881

N02AX02

ATC

tramadol; systemic, rectal

1.5

32.1

1612

12481

R47.0

ICD-10 Finland

Dysphasia and aphasia

7.7

31.4

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

31.3

674

4277

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

+∞

31.3

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

31.1

280

1333

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

30.7

379

2028

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

30.5

231

1023

R41.0

ICD-10 Finland

Disorientation, unspecified

3.2

30.3

119

375

N06AX11

ATC

mirtazapine; oral

1.5

30.2

1262

9370

NK6AI

NOMESCO Finland

Other cone beam scan

58.9

30.1

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

29.7

525

3147

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

29.6

274

1319

R55

ICD-10 Finland

Syncope and collapse

1.9

29.1

398

2203

I72.8

ICD-10 Finland

Aneurysm and dissection of other specified arteries

8.5

28.7

WX872

NOMESCO Finland

Intensive care

2.4

28.6

197

836

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

28.3

859

5924

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

27.9

1628

12873

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.8

27.8

232

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

27.8

420

2400

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.5

27.7

280

N19

ICPC

Speech disorder

5.7

27.4

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

8.3

27.4

N05AH04

ATC

quetiapine; oral

1.7

27.3

600

3816

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

27.3

162

641

C08CA06

ATC

nimodipine; systemic

62.5

27.0

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.4

26.9

158

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

26.7

1336

10228

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

24.9

26.5

C08CA13

ATC

lercanidipine; oral

1.7

26.5

572

3618

Z3226

NOMESCO Finland

Physiotherapist

1.6

26.3

634

4125

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

+∞

26.1

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

26.0

234

1113

Z94.0

ICD-10 Finland

Kidney transplant status

4.7

25.9

130

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

25.9

295

1533

Z72.0

ICD-10 Finland

Tobacco use

3.0

25.9

117

401

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

25.9

1067

7845

Z3231

NOMESCO Finland

Registered nurse

1.5

25.7

933

6675

N03AX09

ATC

lamotrigine; oral

2.5

25.6

168

697

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

5.8

25.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

25.3

1298

9959

PA2BM

NOMESCO Finland

MRI examination of vessels in the head with 3 Tesla magnet

58.4

25.0

R53

ICD-10 Finland

Malaise and fatigue

1.5

25.0

862

6094

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

3.9

24.9

194

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

10.1

24.7

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

7.3

24.6

C08CA05

ATC

nifedipine; systemic

2.2

24.3

211

989

N06AB04

ATC

citalopram; systemic

1.6

24.2

745

5129

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

24.2

207

964

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

24.2

392

2285

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.2

24.1

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

+∞

24.0

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

+∞

24.0

N05BA04

ATC

oxazepam; oral

1.5

23.9

941

6831

C10AX09

ATC

ezetimibe; oral

1.6

23.9

637

4240

N06AB10

ATC

escitalopram; oral

1.6

23.8

690

4684

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

7.7

23.8

G45.3

ICD-10 Finland

Amaurosis fugax

3.5

23.7

244

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

125.8

23.6

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

23.6

1035

7679

C09CA06

ATC

candesartan; oral

1.5

23.3

917

6650

H47.2

ICD-10 Finland

Optic atrophy

8.8

23.3

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

23.2

425

2564

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

6.7

22.9

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

22.9

231

1148

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

4.2

22.9

148

H02AB06

ATC

prednisolone; systemic

1.4

22.7

1714

14025

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

22.7

1082

8146

N06AX16

ATC

venlafaxine; oral

1.7

22.7

520

3331

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

231.4

22.6

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

23.0

22.6

C09AA05

ATC

ramipril; oral

1.5

22.4

825

5896

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

22.4

160

691

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

45.3

22.3

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.5

22.2

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

22.1

494

3144

I61.5

ICD-10 Finland

Intracerebral haemorrhage, intraventricular

+∞

21.9

R03BB04

ATC

tiotropium bromide; inhalant

1.8

21.7

360

2109

N05BA01

ATC

diazepam; systemic, rectal

1.7

21.6

455

2849

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

21.6

761

5382

C09AA02

ATC

enalapril; systemic

1.6

21.6

652

4460

S18

ICPC

Laceration/cut

1.4

21.5

1719

14158

R4110

NOMESCO Finland

Physiotherapy

1.5

21.1

969

7224

N03AX12

ATC

[U] gabapentin; oral

1.6

21.1

596

4013

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

21.0

365

2169

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

+∞

20.8

4309X

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS NUD]

+∞

20.8

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

21.6

20.8

S06.0

ICD-10 Finland

Concussion

1.8

20.6

360

2140

R06.0

ICD-10 Finland

Dyspnoea

1.5

20.4

963

7208

R11

ICD-10 Finland

Nausea and vomiting

1.8

20.2

305

1738

R4130

NOMESCO Finland

Speech therapy

3.0

20.1

302

SPAT1216

SPAT

Assessment of functional ability

1.6

20.1

514

3379

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

20.1

171

796

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

19.9

221

1137

ZXA00

NOMESCO Finland

Right side

1.5

19.9

909

6761

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

19.8

147

646

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

19.7

379

2314

127

Kela drug reimbursment

Transplant complication

3.5

19.7

198

N06AA09

ATC

amitriptyline; systemic

1.7

19.6

363

2193

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

19.6

827

6052

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.5

19.6

199

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.9

19.6

334

I67.2

ICD-10 Finland

Cerebral atherosclerosis

17.8

19.5

A02BC03

ATC

lansoprazole; oral

1.4

19.4

1033

7895

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.8

19.4

358

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

5.1

19.3

C09CA01

ATC

losartan; oral

1.4

19.2

936

7035

SPAT1301

SPAT

No procedures

1.4

19.2

1026

7847

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

19.1

159

733

N05CF01

ATC

zopiclone; oral

1.4

19.1

1119

8696

PA7CC

NOMESCO Finland

Very extensive angiography of arteries of neck and brain

34.5

18.9

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

+∞

18.8

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

5.3

18.7

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

18.6

294

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

190.9

18.5

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

18.5

535

3613

H93.1

ICD-10 Finland

Tinnitus

1.8

18.5

272

1536

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

18.5

254

1405

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

18.4

1526

12536

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

18.2

698

5003

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

4.8

18.2

M03BX01

ATC

baclofen; systemic

3.0

18.2

260

R51.81

ICD-10 Finland

Facial pain NOS

2.6

18.1

102

394

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

18.0

266

1504

ZXY02

NOMESCO Finland

Neuropsychologist

6.3

18.0

H34.1

ICD-10 Finland

Central retinal artery occlusion

6.5

17.9

C03CA01

ATC

furosemide; systemic

1.4

17.9

951

7248

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

5.5

17.9

G44.0

ICD-10 Finland

Cluster headache syndrome

4.0

17.9

126

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

17.7

587

4081

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

17.7

210

1107

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

17.5

798

5910

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

17.2

453

2990

R50.9

ICD-10 Finland

Fever, unspecified

1.6

17.2

492

3310

N03AX16

ATC

[U] pregabalin

1.4

17.2

813

6062

N06AX21

ATC

duloxetine; oral

1.6

17.0

434

2845

A28

ICPC

Limited function/disability NOS

1.5

16.8

568

3962

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

16.8

474

3181

J01DB01

ATC

cefalexin; oral

1.4

16.7

2946

27034

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

+∞

16.7

I65.0

ICD-10 Finland

Occlusion and stenosis of vertebral artery

+∞

16.7

I60.5

ICD-10 Finland

Subarachnoid haemorrhage from vertebral artery

+∞

16.7

A02BC01

ATC

omeprazole; systemic

1.4

16.7

921

7053

G40.10

ICD-10 Finland

Simple partial seizures

5.5

16.6

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.9

16.6

269

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

6.7

16.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

16.5

729

5360

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.8

16.4

134

SPAT1310

SPAT

Counselling related to known health issue

1.4

16.4

1037

8119

M54.5

ICD-10 Finland

Low back pain

1.4

16.4

1283

10393

AN1

Coronary angiography

1.7

16.3

337

2095

W19

ICD-10 Finland

Unspecified fall

1.7

16.3

320

1964

J01MA02

ATC

ciprofloxacin; systemic

1.4

16.2

1308

10639

A02BC02

ATC

pantoprazole; systemic

1.4

16.2

2493

22304

R04.0

ICD-10 Finland

Epistaxis

1.8

16.0

254

1469

-, ,

ICD-10 Finland

2.6

15.6

352

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

15.6

939

7283

XA400

NOMESCO Finland

EEG

6.0

15.6

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

15.5

304

1864

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

15.5

785

5912

Z2446

NOMESCO Finland

Social worker

1.9

15.4

199

1078

P20

ICPC

Memory disturbance

1.5

15.4

447

3016

R07.3

ICD-10 Finland

Other chest pain

1.6

15.3

363

2335

Z00.0

ICD-10 Finland

General medical examination

1.5

15.2

634

4607

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

15.0

221

1248

N06AX12

ATC

bupropion; oral

1.8

15.0

214

1198

WX704

NOMESCO Finland

Intubation

1.7

14.9

290

1774

ZXA05

NOMESCO Finland

Left side

1.4

14.9

803

6106

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

14.9

154

774

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

14.8

157

795

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.2

14.8

179

N05BA09

ATC

clobazam; oral

6.1

14.7

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

14.6

107

468

C02AC05

ATC

moxonidine; oral

2.0

14.6

160

820

AAC20

NOMESCO Finland

Anastomosis to intracranial vessel

+∞

14.6

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

14.6

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

14.6

374

2452

A06AD11

ATC

lactulose; oral

1.5

14.6

455

3117

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

14.6

306

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

14.5

207

1158

WX730

NOMESCO Finland

Conventional respirator

3.2

14.5

171

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

14.4

381

2515

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.8

14.4

114

N17

ICPC

Vertigo/dizziness

1.5

14.4

436

2968

SPAT1229

SPAT

Assessment of need for aid

1.7

14.4

245

1446

SPAT1254

SPAT

Administration of medicine

1.5

14.3

433

2947

G40

ICD-10 Finland

Epilepsy

4.3

14.3

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

14.3

645

4752

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

14.2

141

697

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

14.2

414

2792

N07BB01

ATC

disulfiram; oral

2.1

14.2

137

670

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

4.7

14.2

UJF32

NOMESCO Finland

Coloscopy

1.4

14.2

903

7051

N03AX11

ATC

topiramate; oral

2.5

14.1

364

G51.0

ICD-10 Finland

Bell palsy

2.4

14.1

413

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

14.1

442

3030

N03AE01

ATC

clonazepam; systemic

1.9

14.1

194

1074

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.3

14.1

159

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

14.1

502

3535

C08CA02

ATC

felodipine; oral

1.6

14.0

303

1905

Z71.8

ICD-10 Finland

Other specified counselling

1.3

14.0

1131

9154

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

13.9

956

7555

R03AC02

ATC

salbutamol; inhalant

1.3

13.8

1891

16455

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

13.8

239

1416

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

23.8

13.8

183

Kela drug reimbursment

Lamotrigin and topiramate

4.5

13.8

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.5

13.8

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

13.7

758

5778

A11CC03

ATC

alfacalcidol; systemic

2.5

13.7

351

N05CD07

ATC

temazepam; oral

1.6

13.7

365

2414

M03BX02

ATC

tizanidine; oral

1.3

13.6

2211

19670

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.0

13.5

138

690

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

34.1

13.5

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

10.9

13.5

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

140.5

13.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

13.4

391

2638

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.6

13.4

290

WX402

NOMESCO Finland

General anaesthesia

1.4

13.3

764

5860

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

9.7

13.2

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

13.1

469

3301

P17

ICPC

Tobacco abuse

3.1

13.1

177

N28

ICPC

Limited function/disability (N)

2.8

13.0

220

B01AC22

ATC

prasugrel; oral

5.2

12.9

N02AA05

ATC

oxycodone; systemic

1.4

12.9

601

4446

A01

ICPC

Pain general/multiple sites

1.6

12.8

356

2374

SPAT1153

SPAT

Removal of sutures

1.3

12.7

1069

8677

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

12.7

758

5842

M79.6

ICD-10 Finland

Pain in limb

1.3

12.7

1551

13243

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

12.7

631

4720

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.1

12.6

122

598

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

12.6

404

2779

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

12.6

606

4505

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

12.6

1375

11567

A04

ICPC

Weakness/tiredness general

1.5

12.6

490

3506

C09BA02

ATC

enalapril and diuretics; systemic

1.7

12.5

253

1564

I62.1

ICD-10 Finland

Nontraumatic extradural haemorrhage

+∞

12.5

PA7BC

NOMESCO Finland

Extensive angiography of arteries of neck and brain

+∞

12.5

I62.9

ICD-10 Finland

Intracranial haemorrhage (nontraumatic), unspecified

+∞

12.5

L04AA06

ATC

mycophenolic acid; systemic

2.6

12.5

277

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

12.5

544

3975

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

130.4

12.4

PA7KT

NOMESCO Finland

Temporary closure of brain artery

130.4

12.4

G50.1

ICD-10 Finland

Atypical facial pain

2.5

12.4

290

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.6

12.3

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

4.7

12.3

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.6

12.3

267

M48.0

ICD-10 Finland

Spinal stenosis

1.5

12.3

415

2886

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

12.3

527

3840

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

12.2

358

2419

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

12.1

253

1578

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

3.3

12.0

139

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

12.0

134

693

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

12.0

334

2230

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

12.0

147

785

H02AB04

ATC

methylprednisolone; systemic

1.4

12.0

483

3478

SPAT1284

SPAT

Extensive health certificate

2.4

11.9

356

J01DA01

ATC

[U] cefalexin

1.3

11.9

2085

18569

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

11.9

205

1214

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

46.8

11.9

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.5

11.9

308

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

11.8

160

882

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.4

11.8

126

R52.2

ICD-10 Finland

Other chronic pain

1.9

11.8

140

740

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

11.7

1245

10409

R52.9

ICD-10 Finland

Pain, unspecified

1.5

11.7

346

2339

R13

ICD-10 Finland

Dysphagia

1.7

11.7

234

1442

I63

ICD-10 Finland

Cerebral infarction

16.4

11.6

G44.8

ICD-10 Finland

Other specified headache syndromes

3.0

11.6

168

A02BC05

ATC

esomeprazole; systemic

1.3

11.6

1412

12007

A12AA04

ATC

calcium carbonate; oral

2.8

11.6

201

SPAT1240

SPAT

Therapeutic discussion

1.6

11.5

292

1910

I67.7

ICD-10 Finland

Cerebral arteritis, not elsewhere classified

+∞

11.5

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

+∞

11.5

43099

ICD-8 Finland

Subarachnoid haemorrhage, Without mention of hypertension

+∞

11.5

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

11.4

2475

22572

PA6YT

NOMESCO Finland

Dilatation of carotid artery with stent

120.4

11.4

A12BA01

ATC

potassium chloride; oral

2.0

11.2

119

604

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.4

11.2

115

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

4.3

11.2

SPAT1053

SPAT

Memory test

1.5

11.1

404

2849

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

3.0

11.1

167

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

11.1

872

6991

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

11.1

294

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

11.0

154

857

J01AA02

ATC

doxycycline; systemic

1.3

11.0

2804

26035

X58

ICD-10 Finland

Exposure to other specified factors

1.4

11.0

465

3373

N02BF01

ATC

gabapentin; oral

1.5

11.0

363

2511

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.3

10.9

122

L04AD02

ATC

tacrolimus; systemic

3.3

10.9

122

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

10.9

227

1414

C10AA04

ATC

fluvastatin; oral

1.6

10.9

261

1683

N06AB06

ATC

sertraline; oral

1.5

10.9

344

2359

SPAT1263

SPAT

Sampling

1.3

10.9

1309

11096

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

10.8

249

1590

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.2

10.8

133

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

10.7

928

7532

S01.0

ICD-10 Finland

Open wound of scalp

1.6

10.7

233

1468

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.2

10.5

130

N03AX18

ATC

lacosamide; systemic

4.4

10.5

G47.3

ICD-10 Finland

Sleep apnoea

1.3

10.5

766

6073

J67.1

ICD-10 Finland

Bagassosis

110.3

10.4

I60

ICD-10 Finland

Subarachnoid haemorrhage

+∞

10.4

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.1

10.3

479

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.0

10.3

148

AAK00

NOMESCO Finland

Cranioplasty

18.8

10.2

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

10.2

274

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

2.8

10.2

170

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

10.2

143

798

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

10.1

163

948

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.7

10.1

199

C07AA05

ATC

propranolol; systemic

1.3

10.1

642

4985

M79.1

ICD-10 Finland

Myalgia

1.4

10.0

484

3593

K89

ICPC

Transient cerebral ischaemia

3.5

10.0

H02.4

ICD-10 Finland

Ptosis of eyelid

2.0

10.0

106

540

C03AA03

ATC

hydrochlorothiazide; oral

1.5

9.9

280

1874

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

9.9

181

1091

P03

ICPC

Feeling depressed

1.5

9.8

270

1798

SPAT1252

SPAT

Overall medication plan or its review

1.6

9.7

201

1251

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

3.2

9.7

116

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

9.7

334

2330

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

9.7

110

573

I61

ICD-10 Finland

Intracerebral haemorrhage

55.1

9.6

S22.3

ICD-10 Finland

Fracture of rib

1.6

9.6

229

1475

C09DA06

ATC

candesartan and diuretics; oral

1.6

9.6

255

1684

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.5

9.6

222

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.8

9.5

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

9.5

616

4794

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

9.5

148

854

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

9.5

417

3047

C03DA01

ATC

spironolactone; oral

1.4

9.4

371

2655

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

9.4

331

2318

P15

ICPC

Chronic alcohol abuse

2.1

9.4

441

G91.1

ICD-10 Finland

Obstructive hydrocephalus

7.5

9.4

PA2AM

NOMESCO Finland

Simple MRI examination of vessels in the head with 3 Tesla magnet

+∞

9.4

I61.6

ICD-10 Finland

Intracerebral haemorrhage, multiple localized

+∞

9.4

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.9

9.4

116

623

R95

ICPC

Chron obstructive pulmonary disease

2.0

9.3

497

C01DA14

ATC

isosorbide mononitrate; oral

1.4

9.3

399

2899

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

9.3

187

1155

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.6

9.3

202

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

9.3

301

2075

P01AB01

ATC

metronidazole; oral, rectal

1.2

9.3

1350

11645

L28

ICPC

Limited function/disability (L)

1.3

9.2

593

4605

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.9

9.2

141

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.1

9.2

378

EBA00

NOMESCO Finland

Extraction of tooth

1.3

9.2

1138

9634

N06AX03

ATC

mianserin; oral

1.7

9.2

154

907

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.4

9.2

S06.2

ICD-10 Finland

Diffuse brain injury

3.4

9.2

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

9.1

469

3517

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

9.1

605

4720

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

9.1

490

3701

N30.0

ICD-10 Finland

Acute cystitis

1.4

9.1

547

4204

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

9.1

498

3772

B01AB05

ATC

enoxaparin; parenteral

1.3

9.1

1019

8522

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.0

9.1

C10AA07

ATC

rosuvastatin; oral

1.3

9.1

1182

10061

J01FF01

ATC

clindamycin; systemic

1.3

9.1

865

7092

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.1

9.1

116

SPAT1234

SPAT

Support of social functional capacity

1.8

9.0

142

821

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

8.9

566

4384

R40.2

ICD-10 Finland

Coma, unspecified

3.6

8.9

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

7.4

8.9

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

8.9

119

655

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

8.9

237

N88

ICPC

Epilepsy

4.3

8.9

H34.2

ICD-10 Finland

Other retinal artery occlusions

4.3

8.9

R02

ICPC

Shortness of breath/dyspnoea

1.4

8.8

431

3203

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.5

8.8

R60.0

ICD-10 Finland

Localized oedema

1.4

8.8

403

2966

SPAT1260

SPAT

Consultation of another employee

1.4

8.8

526

4042

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

8.7

121

674

KBV00

NOMESCO Finland

Insertion of stent into ureter

3.7

8.7

75310

ICD-8 Finland

Congenital anomalies of urinary system, Ren polycysticus bilateralis

50.1

8.7

G94.2

ICD-10 Finland

Hydrocephalus in other diseases classified elsewhere

50.1

8.7

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.5

8.6

K86

ICPC

Hypertension uncomplicated

1.4

8.6

458

3452

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

8.6

875

7226

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

9.0

8.5

F80.1

ICD-10 Finland

Expressive language disorder

3.8

8.5

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

27.6

8.5

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.9

8.5

137

ZY010, ,

SPAT

2.5

8.5

218

XX3XW, ,

NOMESCO Finland

4.2

8.4

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

8.4

363

2640

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.8

8.4

117

653

G41.9

ICD-10 Finland

Status epilepticus, unspecified

4.9

8.4

I61.3

ICD-10 Finland

Intracerebral haemorrhage in brain stem

+∞

8.3

PA7YT

NOMESCO Finland

Very extensive carotis artery PTA with stent

+∞

8.3

43399

ICD-8 Finland

Cerebral thrombosis, Without mention of hypertension

+∞

8.3

I69.4

ICD-10 Finland

Sequelae of stroke, not specified as haemorrhage or infarction

+∞

8.3

AAC10

NOMESCO Finland

Reinforcement of intracranial aneurysm wall

+∞

8.3

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.3

8.3

282

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

8.3

478

3647

K99

ICPC

Cardiovascular disease other

2.1

8.3

394

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.3

8.3

276

F06.7

ICD-10 Finland

Mild cognitive disorder

2.0

8.3

449

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

8.3

605

4781

Z08

ICPC

Social welfare problem

2.7

8.3

167

N05AX08

ATC

risperidone; systemic

1.5

8.3

224

1488

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

3.5

8.2

N05CF02

ATC

zolpidem; oral

1.3

8.2

569

4462

AA1AA

NOMESCO Finland

Head X-ray examination

3.4

8.2

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

1.9

8.2

100

535

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.2

8.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

8.2

240

1621

GBB00

NOMESCO Finland

Tracheostomy

3.0

8.2

118

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

8.2

589

4646

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.9

8.2

129

SPF30

NOMESCO Finland

Relining of denture

2.3

8.1

253

8000/0-C70.0

ICD-O-3

Neoplasm, benign of cerebral meninges

4.4

8.1

G43.8

ICD-10 Finland

Other migraine

2.4

8.1

216

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

11.7

8.1

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

8.1

216

1431

J01FA06

ATC

roxithromycin; oral

1.2

8.1

1313

11419

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

4.1

8.0

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

8.0

140

836

40199

ICD-8 Finland

Essential benign hypertension

2.5

8.0

194

SPAT1210

SPAT

Application of cast or individual aid

1.7

7.9

130

762

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.4

7.9

225

ZYC01, ,

SPAT

1.4

7.9

312

2235

SPAT1312

SPAT

General health counselling

1.3

7.9

944

7936

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

7.9

275

1925

H81.3

ICD-10 Finland

Other peripheral vertigo

1.9

7.9

465

K08.3

ICD-10 Finland

Retained dental root

1.5

7.9

238

1619

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.6

7.8

170

2616

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

7.8

1190

10271

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

7.8

242

1655

XX4BW, ,

NOMESCO Finland

10.8

7.8

R4120, ,

SPAT

2.6

7.7

173

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

7.7

133

790

M54.2

ICD-10 Finland

Cervicalgia

1.5

7.7

263

1832

IHZ05, ,

SPAT

1.8

7.7

102

561

A01AB09

ATC

miconazole; local oral

1.5

7.7

259

1802

G70.0

ICD-10 Finland

Myasthenia gravis

4.5

7.6

SPAT1101

SPAT

Orthostatic test

1.8

7.6

120

695

P18

ICPC

Medication abuse

3.7

7.6

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

7.6

166

1049

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

7.6

289

2056

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.9

7.6

118

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

7.6

345

2535

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

7.6

801

6634

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

7.5

241

1658

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

3.2

7.5

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

7.5

1505

13342

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

7.5

100

552

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

7.5

197

1301

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.1

7.5

302

K59.0

ICD-10 Finland

Constipation

1.6

7.5

166

1054

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.0

7.5

103

J20

ICD-10 Finland

Acute bronchitis

1.4

7.4

319

2319

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

3.9

7.4

H53

ICD-10 Finland

Visual disturbances

2.9

7.4

114

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

7.4

129

770

C09CA03

ATC

valsartan; oral

1.4

7.4

289

2067

SPAT1097

SPAT

Recording of ECG

1.3

7.4

437

3348

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.9

7.4

120

C07AG02

ATC

carvedilol; oral

1.6

7.4

166

1058

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.8

7.3

102

570

C08DA01

ATC

verapamil; systemic

1.7

7.3

121

712

I67.5

ICD-10 Finland

Moyamoya disease

+∞

7.3

YKA02

NOMESCO Finland

Excision of kidneys from cadaver donor

+∞

7.3

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

+∞

7.3

PA2CM

NOMESCO Finland

Extensive MRI examination of vessels in the head with 3 Tesla magnet

+∞

7.3

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

7.3

173

1116

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

7.3

1152

9968

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

7.2

436

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

7.2

187

1230

N06AX26

ATC

vortioxetine; oral

1.5

7.2

201

1344

N89

ICPC

Migraine

1.9

7.2

465

F05

ICPC

Visual disturbance other

1.8

7.2

101

566

J01EA01

ATC

trimethoprim; systemic

1.3

7.2

820

6845

G43.3

ICD-10 Finland

Complicated migraine

2.3

7.2

223

V03AE02

ATC

sevelamer; oral

3.9

7.2

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

7.1

302

2191

PA7DG

NOMESCO Finland

Very extended MRI examination of vessesl in brain and neck with high intensity magnet

20.0

7.1

SPAT1050

SPAT

Extensive neurological examination

2.1

7.1

308

AA1CG, ,

SPAT

2.6

7.1

151

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

7.1

168

1084

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

7.1

288

2075

I72.9

ICD-10 Finland

Aneurysm and dissection of unspecified site

12.0

7.1

A41.9

ICD-10 Finland

Sepsis, unspecified

1.8

7.1

533

F10.24

ICD-10 Finland

Alcohol depence active use

2.4

7.0

200

UJH02

NOMESCO Finland

Anoscopy

1.7

7.0

129

781

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

7.0

511

4033

A05

ICPC

Feeling ill

1.6

7.0

145

906

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.1

7.0

324

PD5AD

NOMESCO Finland

CT of aorta

2.0

7.0

379

PEN23

NOMESCO Finland

Plastic repair of femoral artery

3.2

7.0

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

6.9

309

2262

C07AB04

ATC

acebutolol; systemic

2.4

6.9

189

137

Kela drug reimbursment

Uraemia requiring dialysis

3.0

6.9

N29

ICPC

Neurological sympt/complt other

2.2

6.9

272

J01CA04

ATC

amoxicillin; systemic

1.2

6.9

2799

26450

S06.3

ICD-10 Finland

Focal brain injury

2.8

6.9

119

A03

ICPC

Fever

1.3

6.9

474

3711

OAB47, ,

SPAT

1.6

6.9

144

902

N02BF02

ATC

pregabalin; oral

1.5

6.9

217

1490

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

6.9

215

1474

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

6.8

459

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

6.8

725

5999

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.3

6.8

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.8

760

6325

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

10.9

6.8

C08CA10

ATC

nilvadipine; oral

2.1

6.8

274

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

6.8

533

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.3

6.8

216

I67

ICD-10 Finland

Other cerebrovascular diseases

40.1

6.8

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

6.7

288

2093

G81.1

ICD-10 Finland

Spastic hemiplegia

16.7

6.7

N06AG02

ATC

moclobemide; oral

1.7

6.7

127

775

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

6.7

179

1186

C07AB03

ATC

atenolol; systemic

1.6

6.7

158

1018

K92.1

ICD-10 Finland

Melaena

1.6

6.7

148

939

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.1

6.7

282

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

3.1

6.7

A02BA02

ATC

ranitidine; systemic

1.3

6.7

584

4719

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.2

6.7

224

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

6.7

218

1508

C02EA02, ,

ATC

1.8

6.7

100

573

P76

ICPC

Depressive disorder

1.5

6.6

177

1173

G45.4

ICD-10 Finland

Transient global amnesia

1.9

6.6

400

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

5.9

6.6

G40.89

ICD-10 Finland

Other epilepsy

5.5

6.6

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.9

6.6

401

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

6.6

263

1890

D68.8

ICD-10 Finland

Other specified coagulation defects

2.7

6.6

128

SPAT1058

SPAT

PEF monitoring instruction

1.4

6.6

244

1730

SFA10

NOMESCO Finland

One-surface restoration

1.2

6.6

1798

16339

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

10.0

6.5

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

2.6

6.5

140

J96.0

ICD-10 Finland

Acute respiratory failure

2.5

6.5

158

R25.2

ICD-10 Finland

Cramp and spasm

1.9

6.5

396

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

6.5

383

2933

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

6.5

110

653

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.8

6.5

475

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.2

6.5

227

TK800

NOMESCO Finland

Hemodialysis

2.1

6.5

293

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

6.4

505

2132

FHL

Ventricular operators sunt

70.0

6.4

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

6.4

220

1536

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

7.4

6.4

A07AA02

ATC

nystatin; oral

1.5

6.4

174

1160

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

6.4

700

5811

OAB42, ,

SPAT

1.3

6.3

402

3111

AAF15

NOMESCO Finland

Ventriculoatrial shunt

6.5

6.3

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.7

6.3

105

620

CBK11

NOMESCO Finland

Operation for lagophtalmus with implant

11.0

6.3

CEC30

NOMESCO Finland

Resection of extraocular muscle

9.3

6.3

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

3.5

6.3

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.6

6.3

146

939

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.6

6.3

133

837

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

18.0

6.3

PA1BC

NOMESCO Finland

Extensive aortocervical angiongraphy with X-ray (including 1 or 2 selective injections)

18.0

6.3

K11.2

ICD-10 Finland

Sialoadenitis

1.7

6.3

100

584

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

3.8

6.3

8010/3-C80.9

ICD-O-3

Carcinoma, NOS, of unknown primary site

+∞

6.2

I65.1

ICD-10 Finland

Occlusion and stenosis of basilar artery

+∞

6.2

2164

FHL

Crotigree

+∞

6.2

PA8KT

NOMESCO Finland

Intravascular temporary closure of carotid artery

+∞

6.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

6.2

198

1362

AA9PW, ,

NOMESCO Finland

26.7

6.2

PA2JT

NOMESCO Finland

Very extensive embolisation of arterio-venous malformation of the brain

26.7

6.2

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2.8

6.2

109

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.4

6.2

168

SPAT1243

SPAT

Psychiatric/psychological examination

2.0

6.2

298

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.7

6.2

107

639

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.1

6.2

265

PD1AE

NOMESCO Finland

Ultrasound examination of abdominal aortta

3.5

6.2

ZXH06, ,

SPAT

1.5

6.1

158

1040

L17

ICPC

Foot/toe symptom/complaint

1.2

6.1

997

8621

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

6.1

198

1368

P06

ICPC

Sleep disturbance

1.3

6.1

386

2986

K29

ICPC

Cardiovascular sympt/complt other

1.6

6.1

126

788

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

3.8

6.1

L01

ICPC

Neck symptom/complaint

1.3

6.1

510

4099

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.0

6.1

M79.7

ICD-10 Finland

Fibromyalgia

1.7

6.1

111

673

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

6.1

228

1621

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

6.1

369

2839

J01MA14

ATC

moxifloxacin; systemic

1.4

6.1

263

1918

N06AA12

ATC

doxepin; systemic

1.5

6.0

152

997

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

6.0

754

6348

IAA01, ,

SPAT

3.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

303

165

19.90

307.65

1.5

1.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1110

3862

3.67

261.55

7.5

7.6

14.21

12.41

kpa

14.85

1074

3718

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1110

3864

3.66

261.31

7.6

7.7

5.12

5.13

kpa

0.15

1076

3717

(3003396) Base excess in Arterial blood by calculation

1102

3830

3.66

259.90

7.4

7.6

0.82

1.04

mmol/l

1.06

905

3146

(3019977) pH of Arterial blood

1105

3848

3.66

259.81

7.6

7.7

7.41

7.42

0.84

729

2131

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1127

4394

3.24

216.08

2.1

2.0

28.97

29.59

2.62

1098

4276

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1859

9952

2.73

193.86

2.6

2.1

197.76

202.15

u/l

0.07

1792

9356

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

608

1937

3.55

157.24

7.2

9.4

24.20

24.35

mmol/l

0.56

603

1906

(3016502) Oxygen saturation in Arterial blood

862

3438

2.96

152.66

8.7

8.0

96.17

95.70

1.20

837

3324

(3002173) Hemoglobin [Mass/volume] in Arterial blood

812

3219

2.95

144.66

9.1

8.4

122.65

121.22

g/l

1.23

793

3137

(3014007) Fractional oxyhemoglobin in Arterial blood

631

2171

3.29

143.61

8.9

9.3

94.51

93.99

1.64

631

2163

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

621

2164

3.24

138.05

9.0

9.2

1.35

1.30

0.81

621

2150

(3032080) INR in Blood by Coagulation assay

2298

15281

2.31

129.28

15.9

13.4

1.21

1.22

inr

0.38

1945

12650

(3013826) Glucose [Moles/volume] in Serum or Plasma

2729

19672

2.44

125.00

7.3

4.8

6.52

6.68

mmol/l

4.89

2645

18675

(3008152) Bicarbonate [Moles/volume] in Arterial blood

571

2081

3.06

116.39

10.0

6.9

24.79

24.55

mmol/l

0.98

549

1989

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2275

15637

2.16

110.03

8.7

6.4

1.19

1.21

mmol/l

33.78

2151

14428

(3043409) Potassium [Moles/volume] in Arterial blood

325

887

3.92

104.04

6.3

4.0

3.86

3.87

mmol/l

0.12

325

879

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

276

679

4.31

101.71

1.8

1.3

30.55

39.14

e6/l

0.23

219

497

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

278

690

4.27

101.25

1.8

1.3

4787.29

777.50

e6/l

1.32

234

540

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

293

788

3.95

95.59

1.6

1.2

557.96

554.71

mg/l

0.03

279

753

(3044640) Blood type and Crossmatch panel - Blood

1693

10874

2.02

92.54

2.8

2.4

—

(3033658) Prothrombin time (PT) actual/Normal

1390

8333

2.06

91.90

5.1

4.0

94.66

91.71

4.47

1347

8145

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1370

8242

2.05

89.08

2.7

2.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2386

17473

2.01

87.59

9.5

7.2

1.20

1.22

mmol/l

25.49

2148

15088

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

249

706

3.71

75.00

1.5

1.2

3.60

3.70

mmol/l

0.91

236

672

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1836

12712

1.87

74.94

4.5

3.6

33.83

96.46

ng/l

1.03

1384

8788

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

779

4020

2.18

73.97

8.2

6.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2148

15716

1.86

72.68

3.1

2.8

—

estimate

—

(3036489) Thrombin time

306

1013

3.20

72.25

2.1

1.9

19.98

21.23

3.82

276

882

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

565

2629

2.35

68.38

2.8

2.3

6.44

7.10

ug/l

0.25

503

2347

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

140

276

5.23

67.31

2.5

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

605

2997

2.22

62.69

7.9

7.3

1.26

1.31

mmol/l

0.63

591

2948

(3000991) Gas panel - Venous blood

574

2822

2.22

60.44

9.4

8.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1254

8208

1.79

57.12

4.9

3.8

0.57

0.15

—

(3020779) Urea [Moles/volume] in Serum or Plasma

584

3018

2.11

53.71

7.5

7.4

8.29

9.91

mmol/l

6.76

556

2902

(3012095) Magnesium [Moles/volume] in Serum or Plasma

934

5707

1.85

52.61

3.3

3.4

0.82

mmol/l

0.28

879

5384

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

107

215

5.09

50.33

1.7

1.2

2.25

2.24

mmol/l

0.03

202

(3019150) Specific gravity of Urine by Refractometry

1184

7928

1.72

48.00

5.3

4.1

1.02

1.21

kg/l

0.50

762

5301

(3003458) Phosphate [Moles/volume] in Serum or Plasma

755

4433

1.88

47.64

7.2

6.0

1.03

1.04

mmol/l

0.32

704

4102

(3016018) Differential panel - Cerebral spinal fluid

132

333

4.07

46.76

2.0

1.2

—

(3015736) pH of Urine

1875

14275

1.63

45.51

4.5

3.4

6.40

6.22

8.86

1005

8090

(3024561) Albumin [Mass/volume] in Serum or Plasma

2005

15522

1.63

45.45

5.5

5.1

35.44

35.80

g/l

2.03

1916

14564

(3029937) Albumin [Presence] in Urine by Test strip

1389

9906

1.64

43.21

5.2

4.1

0.00

estimate

1.74

347

3464

(3023368) Bacteria identified in Blood by Culture

1293

9121

1.64

41.64

4.7

4.4

—

(3023410) Appearance of Cerebral spinal fluid

117

303

3.95

39.99

2.0

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

514

2824

1.95

39.02

2.7

2.8

65.68

65.63

ml/min/173m2

0.01

219

1187

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1491

11134

1.56

36.51

3.1

2.7

61.38

67.99

u/l

0.40

1395

10314

(3024354) Oxygen [Partial pressure] in Venous blood

499

2780

1.92

36.18

3.7

3.0

4.55

4.52

kpa

0.13

492

2704

(3021447) Carbon dioxide [Partial pressure] in Venous blood

570

3321

1.85

35.93

4.5

3.6

5.88

5.82

kpa

0.64

561

3233

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

131

5.35

34.62

2.5

1.2

—

(3002032) Base excess in Venous blood by calculation

550

3233

1.82

33.52

4.6

3.7

1.71

1.88

mmol/l

0.53

499

2841

(3035350) Ketones [Presence] in Urine by Test strip

2186

18032

1.51

32.08

5.0

3.9

6.37

4.43

estimate

0.17

386

3802

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1560

12029

1.51

31.53

4.4

3.3

—

1.33

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2550

21774

1.54

31.46

5.8

4.6

1229.39

1472.26

e6/l

0.13

305

(3026008) Bacteria identified in Urine by Culture

1376

10337

1.52

31.46

3.7

3.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2211

18335

1.50

31.21

6.5

6.8

10.38

11.26

umol/l

3.26

2134

17487

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

361

1903

1.99

30.55

10.2

16.06

16.00

0.13

344

1834

(3009261) Glucose [Presence] in Urine by Test strip

2190

18169

1.50

30.51

5.0

4.0

0.01

0.10

estimate

0.49

363

3565

(3021601) Nitrite [Presence] in Urine by Test strip

2155

17831

1.49

30.34

4.9

3.9

0.00

estimate

0.80

362

3691

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

129

5.03

30.05

1.7

1.3

48.59

71.00

1.19

(3012544) pH of Venous blood

553

3358

1.76

29.96

4.6

3.7

7.38

0.01

304

1890

(3018418) pH of Serum or Plasma

1378

10551

1.48

27.80

5.2

4.3

7.40

0.29

999

7568

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

237

1111

2.21

27.31

2.2

526.65

707.62

ug/l

0.31

224

1044

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

798

5482

1.58

26.49

2.1

1.9

—

(4034850) Laboratory test

224

1045

2.22

26.12

11.6

9.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

5.49

25.99

2.3

55.56

50.54

umol/l

0.44

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1686

13545

1.45

25.95

4.9

3.9

0.00

0.09

estimate

1.78

302

3023

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

200

896

2.30

25.69

2.4

2.0

98.04

91.98

3.49

193

857

(3036481) Cortisol [Moles/volume] in Serum or Plasma

515

3215

1.70

24.96

2.5

2.4

377.42

373.61

nmol/l

0.18

480

2985

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

203

958

2.18

23.00

3.5

3.0

0.35

0.33

iu/ml

0.59

114

505

(3004119) Hemoglobin [Mass/volume] in Venous blood

366

2127

1.80

22.74

3.6

3.0

127.61

129.47

g/l

0.80

360

2059

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1015

7547

1.47

22.72

1.9

1.7

1.15

1.27

mg/l

0.69

817

5898

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

184

839

2.25

22.67

2.6

2.2

182.34

197.81

1.54

177

790

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

584

3860

1.61

22.46

1.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

611

4091

1.59

22.24

1.9

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

1013

7566

1.47

22.04

3.3

2.7

5.59

5.80

e6/l

0.19

937

6884

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

282

1534

1.91

21.60

7.5

5.3

1.73

1.61

1.08

264

1450

(3019309) Folate [Moles/volume] in Red Blood Cells

775

5506

1.51

21.54

1.8

1.7

1281.80

1168.86

nmol/l

2.69

637

4195

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1305

10263

1.42

21.30

3.0

3.1

1231.59

1197.95

ng/l

0.07

1145

8801

(3027273) Bicarbonate [Moles/volume] in Venous blood

272

1489

1.89

20.43

3.7

3.2

25.36

25.37

mmol/l

0.02

266

1431

(3044889) 12 lead EKG panel

2674

23907

1.42

19.57

4.7

4.0

2.09

2020.70

0.49

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2788

25140

1.43

19.22

5.0

4.5

13.12

12.25

mm/h

2.35

2664

23512

(3003181) Sodium [Moles/volume] in Urine

143

629

2.32

19.20

1.4

71.12

60.73

mmol/l

1.76

118

509

(3007930) Methemoglobin/Hemoglobin.total in Blood

258

1417

1.88

19.17

7.7

5.6

0.92

0.89

0.54

241

1333

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

4.77

19.15

1.6

1.1

26.36

10.20

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

186

912

2.09

19.11

2.7

2.3

3.54

3.62

g/l

0.33

181

871

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1121

8754

1.40

18.44

2.6

2.3

3.00

2.79

mg/l

2.12

1006

7588

(3039000) Anion gap in Blood by calculation

153

708

2.21

18.23

9.5

7.7

10.51

11.28

mmol/l

2.56

136

634

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.75

18.21

1.4

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

2054

17691

1.36

18.17

6.7

6.5

1.85

1.92

e9/l

1.74

1841

15540

(3018572) Chloride [Moles/volume] in Blood

153

709

2.21

18.16

9.5

7.7

106.10

105.12

mmol/l

1.72

136

635

(3002582) Erythrocytes [#/volume] in Urine

1360

10994

1.37

18.05

4.1

3.3

94.67

73.06

e6/l

0.14

1090

8358

(3023183) Ammonium ion [Moles/volume] in Plasma

143

657

2.22

17.35

2.7

3.0

34.09

36.06

umol/l

0.35

128

600

(3015377) Calcium [Moles/volume] in Serum or Plasma

1498

12356

1.35

17.25

3.1

3.7

2.36

mmol/l

0.56

1378

11222

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2891

26403

1.42

17.20

9.2

8.5

78.42

79.12

u/l

0.34

2789

25096

(3030467) Casts [#/volume] in Urine by Automated count

1189

9475

1.37

17.00

3.9

3.1

0.43

0.38

e6/l

0.20

925

6891

(3007853) Bacteria identified in Skin by Aerobe culture

554

3846

1.52

16.79

1.8

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

151

3.61

16.69

1.1

—

(3006315) Basophils [#/volume] in Blood

2008

17364

1.34

16.61

6.7

6.4

0.04

e9/l

0.04

1769

14859

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

4.48

16.57

3.1

2.6

28.51

27.96

umol/l

0.09

(1761868) Lipid panel - Serum or Plasma

1055

13115

0.73

16.35

3.4

3.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1220

9812

1.36

16.30

1.7

19.64

20.72

nmol/l

1.63

1057

8230

(3020630) Protein [Mass/volume] in Serum or Plasma

439

2919

1.57

16.15

2.0

2.9

66.12

66.43

g/l

0.37

406

2688

(3001604) Monocytes [#/volume] in Blood

1998

17315

1.33

16.03

6.7

6.4

0.58

e9/l

0.11

1765

14819

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3418

32406

1.64

15.83

22.0

15.7

23.57

23.79

mg/l

0.15

3025

26634

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

102

424

2.45

15.60

1.5

1.2

5.93

2.56

u/ml

0.84

139

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

101

418

2.46

15.59

1.5

1.2

4.71

3.82

u/ml

0.32

169

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

911

7052

1.39

15.26

2.6

3.0

2.45

2.46

mmol/l

1.02

828

6346

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

786

5942

1.41

15.13

3.4

2.8

1.56

1.03

e6/l

0.96

462

3147

(3013650) Neutrophils [#/volume] in Blood by Automated count

2207

19535

1.32

14.58

9.4

10.1

4.20

4.03

e9/l

3.05

1968

16948

(3047181) Lactate [Moles/volume] in Blood

186

1012

1.88

14.25

8.8

6.5

1.21

1.29

mmol/l

0.76

161

894

(3009466) Valproate [Moles/volume] in Serum or Plasma

389

2.43

14.07

4.0

5.9

358.20

363.24

umol/l

0.11

347

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

367

2434

1.56

13.58

2.4

16.23

21.09

au/ml

0.77

254

(3013115) Eosinophils [#/volume] in Blood

2035

17917

1.30

13.45

7.0

6.6

0.19

e9/l

0.38

1821

15594

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

169

3.17

13.41

1.2

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

830

6451

1.37

13.30

4.5

3.8

361.03

545.65

ng/l

0.49

643

5002

(3019550) Sodium [Moles/volume] in Serum or Plasma

3501

33573

1.68

13.28

26.8

18.2

139.47

139.77

mmol/l

9.04

3462

32954

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

397

2.35

13.01

1.1

124.40

115.94

1.88

347

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

442

2.27

12.95

1.7

1.3

—

nmol/l

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

338

2234

1.56

12.69

1.3

33.75

55.26

au/ml

1.68

159

(3018095) Leukocytes [#/volume] in Urine

1479

12554

1.29

12.66

4.9

3.9

67.84

92.20

e6/l

1.06

1105

8792

(3023103) Potassium [Moles/volume] in Serum or Plasma

3502

33646

1.65

12.39

26.6

18.4

3.97

mmol/l

0.14

3460

32957

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

366

2480

1.53

12.27

1.7

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

506

3659

1.44

12.26

2.0

1.8

1.67

1.45

5.23

451

3224

(4195642) Thrombophilia screening test

403

2.29

12.15

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

3.70

11.65

5.0

5.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1754

15369

1.27

11.14

2.3

2.1

96.90

97.17

pmol/l

0.08

955

7826

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2814

26156

1.31

10.89

5.0

4.6

14.96

14.80

pmol/l

2.97

2641

24089

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

484

2.07

10.39

1.3

355.23

367.89

pmol/l

0.07

424

(40757494) Bilirubin.total [Moles/volume] in Blood

169

2.86

10.31

2.3

2.7

15.36

28.90

umol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

466

3421

1.41

10.31

1.9

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

738

5836

1.33

10.23

3.1

2.6

12.87

13.15

umol/l

0.44

695

5460

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

104

522

2.02

10.17

1.7

1.3

0.67

6.20

nmol/l

0.77

503

(3011985) Renin [Units/volume] in Plasma

104

522

2.02

10.17

1.3

1.5

76.53

60.74

mu/l

0.32

470

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

429

2.13

10.10

1.1

—

(4268621) Lupus anticoagulant assay

295

2.36

10.05

2.7

2.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

171

1019

1.71

9.74

2.1

1.7

0.24

g/l

0.07

164

968

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

383

2748

1.44

9.61

1.6

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

1408

12172

1.25

9.55

3.5

3.4

7.16

7.36

mmol/l

0.94

1231

10273

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

105

542

1.96

9.52

1.7

1.3

0.17

0.30

nmol/l

0.71

(3020191) Ethanol [Moles/volume] in Serum or Plasma

241

2.47

9.51

1.9

1.4

1.39

1.14

promille

0.53

190

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

109

572

1.93

9.42

1.6

1.4

171.40

156.34

au/ml

0.80

160

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

213

2.56

9.37

1.1

9.45

17.28

nmol/l

0.36

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

637

5001

1.33

9.20

3.2

2.6

22.49

22.80

0.22

597

4656

(3004789) Transferrin [Mass/volume] in Serum or Plasma

686

5443

1.32

9.20

3.1

2.6

2.35

2.32

g/l

0.47

644

5046

(3010375) cycloSPORINE [Mass/volume] in Blood

137

2.94

9.07

33.8

29.0

109.03

115.68

ug/l

0.30

114

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

284

2.31

9.05

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

217

1402

1.58

9.01

1.5

1.6

2.00

20.45

iu/ml

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1757

15637

1.23

8.94

3.6

3.0

126.85

127.16

ug/l

0.02

1657

14613

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

299

2.26

8.89

2.8

2.7

—

(3024471) HLA-A [Type]

3.39

8.89

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

173

1061

1.66

8.88

2.1

1.7

1.21

1.20

g/l

0.29

165

1015

(3042936) Bacteria identified in Isolate by Culture

613

4809

1.33

8.88

2.1

2.0

—

(3003694) ABO and Rh group [Type] in Blood

1088

9215

1.25

8.63

1.3

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

204

2.52

8.62

1.1

—

(3024932) HLA-DR beta [Type]

3.35

8.47

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

358

2.12

8.45

1.4

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

226

2.41

8.31

1.1

43.58

41.99

mg/l

0.08

192

(3012516) Albumin [Mass/volume] in Urine

1343

11697

1.23

8.15

3.5

3.4

49.52

39.99

mg/l

0.48

857

7223

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

165

1025

1.64

8.08

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

217

2.42

8.06

1.1

1.0

327.12

285.90

mg/l

0.22

193

(3034426) Prothrombin time (PT)

3.31

8.06

1.2

28.83

28.48

0.07

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

114

644

1.79

7.89

1.6

1.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

489

3781

1.34

7.77

2.3

2.6

1.89

1.81

0.90

444

3379

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

131

774

1.72

7.77

1.3

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

380

2826

1.38

7.75

2.8

2.4

0.45

0.42

e6/l

0.06

355

2701

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

300

2142

1.44

7.73

4.6

3.6

5.18

5.17

kpa

0.07

290

2074

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

372

2758

1.39

7.73

5.7

3.8

95.49

88.93

ng/l

0.62

325

2371

(3009343) pH of Capillary blood

292

2075

1.44

7.72

4.6

3.7

7.42

0.33

256

1731

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

204

1350

1.54

7.66

2.0

2.98

1.83

ug/l

0.59

180

1224

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

463

1.92

7.62

1.7

1.2

0.19

0.22

nmol/l

0.37

364

(40768797) Stomach Pathology biopsy report

624

5010

1.29

7.55

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

179

1154

1.58

7.55

3.1

2.7

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2866

27085

1.25

7.44

28.8

20.3

331.97

331.82

g/l

0.41

2847

26960

(3023520) Reticulocytes [#/volume] in Blood

388

2924

1.36

7.29

2.4

2.7

71.70

69.94

e9/l

0.40

292

2151

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

119

699

1.73

7.23

6.8

5.7

606.14

284.24

iu/ml

0.49

107

(46235355) HIV 1 and 2 tests - Meaningful Use set

589

4723

1.29

7.18

2.0

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1347

11870

1.21

7.00

4.0

4.1

8.39

7.45

mg/mmol

0.30

838

7190

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

331

2.04

6.97

1.5

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

613

4970

1.28

6.83

1.4

444.03

513.94

titre

0.45

139

1089

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

859

7245

1.24

6.82

1.7

14094397.84

38913123.32

pmol/l

1.33

745

6070

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2381

22172

1.20

6.69

4.1

3.3

54.71

48.71

u/l

1.96

2260

20701

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

253

1800

1.44

6.67

4.4

3.5

1.83

2.00

mmol/l

0.33

198

1369

(3025941) Bacteria identified in Stool by Culture

251

1785

1.44

6.64

1.3

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

519

4142

1.29

6.53

1.9

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

438

3419

1.32

6.49

2.1

2.2

0.21

g/l

0.39

406

3210

(44816559) Phosphatidylethanol [Mass/volume] in Blood

189

1283

1.50

6.35

1.9

1.7

0.34

mg/l

0.06

108

586

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

140

889

1.60

6.35

1.6

1.5

8.66

13.13

iu/ml

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

5.16

6.31

2.4

1.2

36.46

69.79

2.70

(3014148) Varicella zoster virus Ab [Titer] in Serum

358

1.94

6.29

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

173

1156

1.52

6.27

1.6

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

283

2.07

6.27

1.4

1.5

310.98

316.40

mu/l

0.07

220

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3191

30687

1.27

6.23

6.2

5.6

1.82

1.93

mu/l

5.90

3017

28385

(3002079) Sodium [Moles/time] in 24 hour Urine

156

2.45

6.18

1.2

1.3

152.08

161.61

mmol/24h

0.31

156

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

293

2.03

6.09

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

293

2.03

6.09

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

293

2.03

6.09

1.5

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

488

3899

1.29

6.08

3.7

4.6

233.06

244.43

u/l

1.09

467

3711

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

175

1181

1.51

6.06

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

221

2.19

6.03

2.0

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1050

9141

1.21

6.00

3.1

2.7

338.06

337.91

umol/l

0.02

949

8084

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.25

5.99

1.0

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

165

2.38

5.96

1.3

1.2

0.52

0.53

ratio

0.06

101

(3026782) Osmolality of Urine

752

6343

1.23

5.88

3.5

2.9

497.37

520.55

mosm/kgh2o

2.54

667

5561

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.79

5.81

3.1

2.5

37.57

21.56

mg/l

—

(3006653) Thiamine [Moles/volume] in Blood

193

2.24

5.75

1.3

1.2

137.69

135.07

nmol/l

0.11

193

(3005719) IgG [Mass/volume] in Serum or Plasma

345

2651

1.33

5.72

2.4

3.0

10.02

10.44

g/l

1.04

309

2449

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1073

0.52

5.68

1.1

0.60

0.63

ratio

0.18

153

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.04

5.64

1.0

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

209

1485

1.43

5.59

1.9

1.8

10.18

6.69

iu/ml

0.76

347

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

168

1145

1.49

5.58

4.9

3.7

24.98

25.03

mmol/l

0.08

156

1066

(3028707) Methadone [Presence] in Urine by Screen method

332

1.91

5.53

2.0

—

(3008295) Osmolality of Serum or Plasma

382

1.85

5.53

1.6

1.4

271.58

275.45

mosm/kgh2o

0.60

293

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

124

793

1.58

5.51

1.4

1.5

—

(3022313) Gas panel - Capillary blood

205

1461

1.43

5.41

4.9

3.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

107

666

1.62

5.32

1.4

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

143

2.39

5.29

1.4

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

137

908

1.53

5.22

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

262

1967

1.36

5.09

1.9

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

880

7636

1.20

5.08

4.7

4.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

137

914

1.52

5.07

1.2

—

(40768446) Kidney Pathology biopsy report

122

2.47

5.03

2.6

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1155

0.57

4.97

1.1

1.2

1.49

1.56

g/l

1.43

1155

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

135

903

1.51

4.94

1.2

1.1

—

(3000494) Fungus identified in Specimen by Culture

520

4294

1.25

4.90

1.7

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3244

31419

1.25

4.89

6.8

6.4

39.02

39.29

mmol/mol

1.30

3074

29400

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

137

2.35

4.82

2.2

2.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

177

2.16

4.71

2.1

1.7

3.96

8.36

nmol/l

0.69

149

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

121

2.41

4.63

1.1

—

(3000330) Specific gravity of Urine by Test strip

114

1702

0.66

4.62

4.5

3.4

1.02

ratio

1.10

105

1541

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

226

2.00

4.60

1.1

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3291

31964

1.25

4.58

5.8

5.3

5.93

mmol/l

0.07

3087

29417

(3011288) Drugs identified in Urine by Screen method Nominal

528

1.64

4.57

2.5

2.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

157

1101

1.44

4.57

1.6

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1290

11645

1.16

4.57

3.7

3.3

31.64

35.33

u/l

1.19

1218

10991

(3017732) Neutrophils [#/volume] in Blood

546

4575

1.23

4.49

2.9

3.3

4.09

4.47

e9/l

1.40

465

3983

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

350

1.78

4.46

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

329

1.81

4.42

2.4

36.12

33.99

iu/ml

0.04

(3052851) Hemolysis interference index of Serum or Plasma

131

893

1.48

4.42

3.3

3.2

2.63

2.17

index

0.27

443

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

223

1.98

4.40

1.1

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.56

4.38

1.6

2.4

148.79

160.35

0.27

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

131

2.30

4.35

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.66

4.32

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

194

1430

1.38

4.27

1.2

1.3

1.24

1.23

u/ml

0.00

112

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

202

1499

1.37

4.27

1.9

2.0

38.72

39.79

u/l

0.29

175

1349

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

212

1.99

4.25

1.5

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

120

2.34

4.24

3.4

2.2

1372.29

30644.84

u/ml

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

207

1.99

4.16

1.5

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.67

4.15

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.54

4.12

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

118

800

1.49

4.11

2.4

2.2

128.98

128.52

g/l

0.07

624

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

323

2577

1.28

4.10

2.9

3.0

173.45

183.88

ng/l

0.21

298

2354

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

279

3525

0.77

4.06

2.2

2.1

3.39

3.44

ratio

0.29

218

2758

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.63

4.06

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

142

2.19

4.04

1.5

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

142

2.19

4.04

1.5

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

133

928

1.45

4.02

1.5

1.6

—

(4198724) Urine methamphetamine measurement

2.68

3.98

1.5

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

432

1.66

3.96

2.3

2.0

31.77

25.27

ug/l

0.20

424

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

275

1.83

3.96

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

411

3392

1.24

3.90

2.4

2.1

0.00

0.01

estimate

1.06

708

(3004716) Salmonella sp identified in Stool by Organism specific culture

198

1487

1.35

3.90

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

143

1021

1.42

3.83

1.9

1.7

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.27

3.82

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

143

1022

1.42

3.81

4.2

3.0

1.55

1.54

mg/l

0.04

129

929

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

587

1.55

3.78

1.6

1.2

280.67

282.14

u/ml

0.02

355

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

128

2.20

3.69

1.5

2.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

168

2.03

3.69

1.0

1.1

1.63

1.19

u/l

—

(3018333) Ribosomal P Ab [Presence] in Serum

267

1.81

3.69

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

304

1.75

3.68

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

122

2.22

3.66

2.7

2.6

0.58

0.61

mmol/l

1.16

122

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

101

682

1.49

3.63

1.4

1.5

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2608

27138

0.87

3.62

25.6

19.5

13.79

13.65

6.27

2588

26779

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.72

3.58

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.36

3.57

1.3

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

122

859

1.43

3.55

2.0

1.7

268.05

293.25

mu/l

0.67

110

791

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

111

2.26

3.54

1.2

0.31

0.30

g/l

0.21

(3028679) Herpes simplex virus Ab [Presence] in Serum

158

2.03

3.50

1.3

1.2

—

(1616796) Gas panel - Central venous blood

105

721

1.47

3.49

4.0

3.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

295

1.74

3.46

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

641

1.49

3.45

1.9

5724.75

4559.55

u/l

0.15

250

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1718

16041

1.13

3.45

2.7

2.5

78.23

79.15

nmol/l

0.67

1570

14544

(3040151) Glucose [Moles/volume] in Capillary blood

357

1.66

3.41

3.9

4.8

6.64

7.18

mmol/l

0.78

299

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

275

2205

1.27

3.39

3.5

4.46

4.47

pmol/l

0.08

247

1974

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

127

2.13

3.35

1.5

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

127

2.13

3.35

1.5

2.0

—

(3017569) Oxygen content in Arterial blood

189

1.91

3.33

1.8

2.5

16.13

16.46

0.18

189

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

167

1256

1.35

3.31

2.1

1.8

—

(3016879) Cocaine [Presence] in Urine

103

713

1.46

3.30

2.0

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

558

1.52

3.30

1.4

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

292

1.72

3.30

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

292

1.72

3.30

1.1

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

135

2.08

3.27

1.8

2.2

125.93

149.11

1.24

127

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

241

1.79

3.26

2.3

1.8

86.08

112.62

ng/l

1.36

241

(3020911) Cortisol [Moles/time] in 24 hour Urine

122

2.14

3.25

1.7

1.5

140.58

365.05

nmol/24h

0.46

122

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3531

34747

1.30

3.25

28.2

20.7

76.90

76.11

umol/l

0.58

3503

34367

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.73

3.15

1.1

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

350

1.64

3.14

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

613

5362

1.17

3.13

3.8

3.0

2.72

2.79

e6/l

0.06

293

2564

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

138

2.04

3.10

1.8

2.3

121.58

161.10

umol/l

0.32

(3012501) Base excess in Blood by calculation

648

1.46

3.10

3.2

4.5

2.41

2.78

mmol/l

0.74

460

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

283

1.71

3.08

1.1

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

144

1073

1.36

3.06

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

603

1.47

3.01

1.9

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

164

1250

1.33

3.00

2.3

1.9

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

204

2574

0.78

2.99

1.8

3.36

3.50

mmol/l

1.08

150

1804

(3048929) Epstein Barr virus Ab [Presence] in Serum

122

890

1.38

2.96

1.5

1.2

—

(3014271) Vancomycin [Susceptibility]

127

2.05

2.96

3.3

2.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3183

31052

1.17

2.91

4.9

4.4

1.35

1.30

mmol/l

3.54

2971

28524

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

100

707

1.43

2.91

1.4

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.32

2.91

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

170

1.89

2.90

1.6

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

170

1.89

2.90

1.6

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

170

1.89

2.90

1.6

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

170

1.89

2.90

1.6

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.71

2.87

1.5

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.39

2.87

3.9

5.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

495

1.50

2.86

1.7

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

257

2091

1.25

2.84

1.9

1.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

117

855

1.38

2.83

1.3

1.22

6.14

u/ml

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.40

2.79

1.1

372.00

304.10

pmol/l

0.40

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

114

832

1.38

2.78

1.2

48.42

43.83

u/ml

—

(21494755) Public health laboratory ask at order entry panel

224

2769

0.80

2.78

1.5

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

281

2315

1.23

2.77

1.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.08

2.77

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.37

2.72

5.7

8.0

7.22

5.26

kpa

0.72

(3000764) Benzodiazepines [Presence] in Urine

108

785

1.39

2.71

2.0

1.7

—

(3027008) Opiates [Presence] in Urine

108

786

1.39

2.69

2.0

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

146

1115

1.32

2.67

1.2

1.3

28.33

41.90

u/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

168

1.85

2.67

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

482

5516

0.86

2.64

3.1

3.3

0.80

0.76

ug/l

0.18

320

3618

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.15

2.64

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.55

2.61

1.1

1.3

103.71

100.22

0.26

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.55

2.61

2.6

7.6

11.29

10.34

0.47

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.34

2.60

1.2

1.1

—

(44806071) Cardiolipin IgM antibody measurement

3.34

2.60

1.2

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

256

2105

1.23

2.59

1.8

2.0

1.28

1.34

g/l

0.20

237

1942

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

193

1537

1.27

2.58

1.8

1.61

1.56

g/l

0.29

173

1330

(3026389) Candida sp identified in Specimen by Organism specific culture

483

1.48

2.56

1.3

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

137

1044

1.32

2.56

1.2

1.3

1.87

5.47

u/ml

0.56

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

114

2.02

2.55

1.2

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

116

863

1.36

2.54

1.1

4.52

4.23

0.08

109

(3018010) Neutrophils/Leukocytes in Blood

1695

16000

1.11

2.53

7.0

6.5

57.99

57.10

2.60

1641

15261

(3028300) Cannabinoids [Presence] in Urine

107

788

1.37

2.50

2.0

1.6

—

(3049717) Cytology report of Urine Cyto stain

155

1207

1.30

2.49

2.6

2.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2028

19335

1.11

2.48

3.0

2.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

120

902

1.34

2.47

1.5

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

587

1.42

2.46

1.3

100.00

414.10

titre

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

151

1.86

2.46

1.0

1.1

1546.86

1513.64

miu/ml

0.05

151

(1761482) Bacteria [#/volume] in Urine by Culture

754

0.65

2.45

5.6

4.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

630

1.41

2.44

1.5

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

502

4410

1.16

2.44

2.2

2.4

163.20

134.90

ug/g

0.74

407

3511

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.90

2.41

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

590

1.42

2.40

1.3

—

265.33

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

131

1.91

2.40

1.0

1.1

1.20

8.45

u/ml

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

458

1.47

2.38

1.1

—

(3022621) pH of Urine by Test strip

226

2739

0.81

2.37

2.9

2.7

6.20

6.08

1.27

151

1835

(3002256) Pathology report gross observation

422

4832

0.86

2.34

1.3

—

(3013512) EKG study

1309

12237

1.11

2.31

3.9

3.5

0.86

0.67

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

126

1.91

2.30

1.3

4.5

61.00

61.93

mg/l

0.04

(3027944) Amphetamines [Presence] in Urine

104

775

1.35

2.29

2.0

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

141

1098

1.30

2.29

1.5

0.06

6.40

iu/ml

0.52

196

(40758558) Short blood count panel - Blood

1146

10646

1.11

2.28

6.5

6.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

860

7869

1.12

2.25

1.3

1.20

1.73

u/ml

1.03

261

2116

(3023419) Bacteria identified in Sputum by Culture

473

1.45

2.24

2.2

2.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

677

1.37

2.20

2.1

5.04

5.08

mmol/24h

0.05

603

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.69

2.20

1.9

2.0

—

(44790049) Parainfluenza type 3 nucleic acid detection

450

1.45

2.19

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

450

1.45

2.19

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

450

1.45

2.19

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

450

1.45

2.19

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

751

6827

1.13

2.19

1.5

2.37

2.44

g/l

0.56

486

4166

(3021879) Hepatitis B virus core Ab [Presence] in Serum

275

2322

1.20

2.17

1.6

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

134

1046

1.29

2.15

1.3

4.65

8.91

u/ml

0.81

159

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.29

2.15

3.8

4.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

227

1886

1.22

2.12

1.7

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

121

935

1.30

2.10

1.7

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.56

2.07

1.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

456

4029

1.15

2.07

3.6

2.8

6.72

7.84

umol/l

0.71

396

3565

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.71

2.07

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.71

2.07

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

276

2348

1.19

2.02

1.2

121.45

145.84

u/ml

0.49

880

(3045424) Erythrocytes [Presence] in Urine

210

1741

1.22

2.02

2.4

2.2

4.17

0.45

estimate

0.42

572

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

170

1380

1.24

2.00

1.9

2.5

2.91

2.90

g/l

0.05

154

1269

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

452

1.42

1.98

1.5

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

157

1265

1.25

1.98

1.8

2.5

0.44

0.94

g/l

1.74

131

1089

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

444

1.43

1.97

1.5

1.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

186

1.67

1.97

1.1

—

(3002030) Lymphocytes/Leukocytes in Blood

1711

16298

1.09

1.95

7.1

6.7

27.13

27.97

2.78

1642

15434

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

1243

1.25

1.92

1.7

2.4

9.58

10.14

g/l

0.98

135

1118

(3024522) Salmonella sp identified in Specimen by Organism specific culture

447

1.42

1.91

1.5

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

324

1.49

1.88

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

590

0.66

1.87

1.3

1.6

1106.46

964.20

mu/l

0.42

465

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3368

33178

1.15

1.87

6.7

6.0

2.59

2.77

mmol/l

26.05

3182

30883

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

213

1.60

1.85

1.2

1.5

11.71

12.86

u/l

0.67

204

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

586

5305

1.12

1.84

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.53

1.83

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.53

1.83

2.2

3.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

124

982

1.27

1.83

2.0

3.13

4.12

iu/l

0.93

411

(3032057) Clostridioides difficile [Presence] in Stool

2.13

1.81

2.6

2.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

319

1.48

1.80

1.5

1.3

18063.14

57990.51

e6/l

1.06

219

(3027456) Digoxin [Moles/volume] in Serum or Plasma

632

1.34

1.80

3.6

3.2

0.94

0.82

nmol/l

0.63

506

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

161

1.68

1.78

1.1

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

161

1.68

1.78

1.1

1.5

—

(44813793) Dust mix specific IgE antibody measurement

216

1.58

1.76

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

142

1149

1.25

1.75

2.2

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

421

1.41

1.75

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

313

1.48

1.75

2.7

3.5

12.24

13.03

index

0.27

176

(3042517) Benzodiazepines panel - Urine

3.34

1.74

2.7

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

422

1.40

1.73

1.5

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

141

1143

1.24

1.72

1.5

1.4

282.82

279.29

ug/g

0.07

677

(3050794) Legionella sp Ab [Presence] in Serum

2.67

1.72

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.92

1.72

1.1

—

(3019069) Monocytes/Leukocytes in Blood

1671

15962

1.08

1.72

7.3

6.8

8.82

8.85

0.19

1596

14949

(3037692) Legionella sp identified in Specimen by Organism specific culture

125

1.76

1.71

1.4

1.3

—

(3006504) Eosinophils/Leukocytes in Blood

1667

15924

1.08

1.71

7.2

6.6

2.81

2.86

0.41

1592

14901

(3008757) Leukocyte morphology finding [Identifier] in Blood

315

1.47

1.71

2.2

4.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

340

1.45

1.70

1.4

1.8

—

1549.09

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

700

1.31

1.69

1.5

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

111

1.81

1.68

1.2

1.5

14.92

15.66

pmol/l

0.20

(3005988) Vibrio sp identified in Specimen by Organism specific culture

425

1.39

1.68

1.5

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

318

2785

1.16

1.67

4.4

4.0

1.22

1.23

mmol/l

3.06

288

2398

(3024139) IgG subclass 3 [Mass/volume] in Serum

375

1.42

1.67

1.4

0.39

g/l

0.01

267

(3028192) IgG subclass 2 [Mass/volume] in Serum

375

1.42

1.67

1.4

2.68

2.88

g/l

0.40

269

(3027135) IgG subclass 1 [Mass/volume] in Serum

375

1.42

1.67

1.4

5.96

6.75

g/l

0.95

267

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.58

1.66

1.1

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.93

1.64

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.44

1.64

9.1

11.9

6.50

5.24

mmol/l

—

(3019225) pH of Specimen

380

3375

1.14

1.64

5.5

4.1

7.34

7.35

0.50

286

2393

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.25

1.63

1.5

2.3

22.25

17.56

umol/l

0.57

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

119

953

1.26

1.63

2.0

2.1

11.33

11.80

mg/l

0.27

110

884

(4062490) Immunoglobulin typing, IgG

369

1.41

1.62

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

593

1.32

1.59

1.4

1.5

0.65

0.73

g/l

0.41

453

(40768800) Prostate Pathology biopsy report

638

0.70

1.59

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

128

1038

1.24

1.58

1.8

2.4

0.00

g/l

-0.00

111

904

(3041806) Other cells [#/volume] in Blood by Manual count

2.43

1.53

1.4

1.6

0.60

0.43

e9/l

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

735

6807

1.10

1.52

1.4

1.3

43.14

30.76

iu/ml

1.18

242

2136

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

1.52

0.0

1.0

—

0.31

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

212

1814

1.18

1.52

2.2

2.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.86

1.50

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

118

956

1.24

1.49

1.8

2.4

0.00

g/l

-0.00

111

903

(4015189) Microbial culture of sputum

1.95

1.48

3.4

2.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.00

1.48

1.2

1.1

1.82

0.72

umol/24h

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

118

959

1.24

1.45

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

706

0.73

1.44

3.7

3.5

29.72

24.44

mg/l

0.33

485

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

152

1270

1.21

1.43

1.6

22.68

16.17

u/ml

0.41

292

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

286

1.44

1.43

1.2

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

196

1.53

1.42

1.8

2.2

7.67

8.30

mmol/l

0.52

196

(3039443) Prostate specific Ag panel - Serum or Plasma

554

0.70

1.42

1.9

1.7

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3231

31836

1.11

1.41

19.5

15.4

80.77

79.69

ml/min/173m2

2.41

3105

29572

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1457

1.19

1.40

1.9

2.4

4.17

4.23

g/l

0.51

156

1345

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1457

1.19

1.40

1.9

2.4

3.61

3.71

g/l

0.49

156

1346

(3022096) Basophils/Leukocytes in Blood

1659

15933

1.07

1.40

7.3

6.8

0.68

0.70

0.82

1578

14890

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.25

1.40

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.18

1.39

1.5

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1458

1.19

1.39

1.9

2.4

7.37

7.42

g/l

0.13

156

1345

(3001019) Free T4 and TSH panel - Serum or Plasma

141

1684

0.83

1.38

2.1

1.8

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.61

1.36

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.61

1.36

1.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

388

3497

1.12

1.36

3.9

3.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.76

1.34

1.7

1.5

0.51

0.37

ug/l

0.66

(3043238) Trisomy 21 risk [Likelihood] in Fetus

285

0.59

1.34

1.2

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

116

951

1.23

1.34

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

107

870

1.24

1.33

1.4

1.3

164.41

212.89

miu/ml

1.10

385

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.13

1.33

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.91

1.33

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.91

1.33

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

105

1.72

1.33

1.1

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

373

3359

1.12

1.33

3.3

2.5

40.54

53.64

u/l

0.41

338

2821

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

193

0.52

1.29

1.2

1.5

54.93

55.72

ug/l

—

193

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

259

1.43

1.29

1.0

606.57

749.61

ng/l

1.05

175

(3017509) Phencyclidine [Presence] in Urine

2.78

1.28

1.0

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

251

1.44

1.28

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

136

1141

1.20

1.26

3.5

3.2

257.52

414.40

mg/l

1.12

459

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

112

922

1.22

1.26

1.6

1.7

—

(40768793) Breast Pathology biopsy report

1012

0.80

1.25

1.3

1.4

—

(3022145) Colonoscopy Study observation

455

4159

1.11

1.25

1.3

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

131

1.61

1.23

1.3

1.4

2.75

3.80

umol/l

1.20

111

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.77

1.22

1.0

1.3

57.10

494.48

ug/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

262

1.42

1.22

1.0

47.75

43.16

ng/l

0.24

181

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

451

1.31

1.22

1.3

1.4

32.86

33.19

u/l

0.02

368

(3009214) Lutropin [Units/volume] in Serum or Plasma

727

1.24

1.21

1.6

1.3

11.10

11.98

u/l

0.21

585

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.16

1.21

1.3

1.2

2.31

1.68

umol/24h

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

276

0.61

1.20

1.2

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

140

1.57

1.20

1.2

1.1

—

4.22

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

418

0.69

1.18

2.6

2.9

13.26

13.24

0.03

413

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

127

1069

1.19

1.16

1.8

2.4

0.00

0.03

g/l

2.05

114

958

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.05

1.15

1.6

1.8

—

(3028433) Virus identified in Specimen by Culture

103

1.65

1.12

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

279

2499

1.13

1.12

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

746

1.23

1.10

1.4

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

201

1.45

1.09

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

244

0.61

1.09

1.4

1.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

260

1.39

1.09

1.0

378.70

325.95

ng/l

0.43

182

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

104

1.64

1.09

1.7

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.38

1.09

1.6

1.4

298.80

341.43

umol/24h

—

(3004616) Nuclear Ab [Presence] in Serum

460

1.29

1.09

1.2

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

364

1.32

1.08

1.1

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

453

1.28

1.06

1.5

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

677

6353

1.08

1.05

1.4

1.3

14.54

11.89

u/ml

0.20

281

2468

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

331

1.33

1.05

4.8

3.9

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

454

1.28

1.05

1.7

—

(3042631) Mycobacterium sp identified in Specimen

472

1.28

1.04

2.5

2.8

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.27

1.03

1.8

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

816

1.21

1.03

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

403

1.29

1.02

2.9

2.3

12.85

21.30

mg/l

2.36

163

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.77

1.00

1.3

1.2

24.99

28.51

nmol/l

0.23

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

282

1.35

1.00

1.4

1.6

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.00

1.00

1.1

1.3

—

687.85

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.00

2.0

2.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3479

34509

1.12

0.99

14.8

12.5

25.85

26.03

u/l

0.22

3416

33540

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.95

0.97

1.3

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.74

0.96

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.77

0.94

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

118

0.51

0.93

2.5

2.7

162.17

152.53

nmol/l

—

103

(3022689) Creatine [Moles/volume] in Urine

120

0.50

0.93

1.7

1.5

6.87

7.86

mmol/l

—

120

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

145

0.55

0.92

1.4

1.1

—

(4281824) Cell count and differential, peritoneal fluid

419

0.74

0.92

1.0

1.2

—

(4024509) Urine culture

186

1650

1.13

0.91

1.9

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

261

1.34

0.91

1.3

1.2

—

68.00

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

261

1.34

0.91

1.3

1.2

137.00

147.06

titre

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

102

1.57

0.90

1.3

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

169

1.42

0.87

2.0

1.6

3.93

2.10

u/field

0.40

125

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

287

0.70

0.85

1.3

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

216

0.65

0.85

1.1

—

(3008898) HLA-B27 [Presence]

130

1132

1.15

0.85

1.1

—

(40768804) Tissue Pathology biopsy report

1385

14313

0.95

0.85

2.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

446

0.76

0.84

1.3

1.4

0.52

0.32

nmol/l

0.34

323

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

137

0.58

0.83

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

399

0.75

0.82

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.88

0.81

1.0

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

382

1.26

0.81

1.2

1.6

68.54

57.23

1.34

230

(3007566) Smooth muscle Ab [Titer] in Serum

114

988

1.16

0.80

1.2

98.89

106.67

titre

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

329

0.73

0.80

1.2

1.5

0.86

0.97

ratio

1.21

203

(1617658) Protocol used for examination of sentinel lymph nodes

329

0.73

0.80

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

329

0.73

0.80

1.2

1.5

1.06

1.19

ratio

0.30

203

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

329

0.73

0.80

1.2

1.5

1.03

1.14

ratio

0.20

203

(3045788) Cell count panel - Pleural fluid

339

1.27

0.78

1.2

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

483

1.23

0.78

1.3

1.2

—

(44806420) Estimation of glomerular filtration rate

384

0.75

0.78

3.0

2.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

327

0.73

0.78

1.2

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

593

1.20

0.78

1.3

1.2

—

(3020650) Glucose [Presence] in Urine

124

0.56

0.77

1.4

1.9

0.43

0.05

estimate

—

124

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3298

32685

1.08

0.77

5.8

5.3

4.50

4.73

mmol/l

32.49

3118

30535

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

591

5593

1.07

0.76

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

1.67

0.74

1.3

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

227

1.32

0.74

1.1

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

615

1.19

0.74

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

615

1.19

0.74

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

469

1.22

0.73

1.1

3.46

3.39

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

193

1.35

0.73

1.5

1.3

1.09

1.27

nmol/l

0.31

138

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.00

0.72

1.0

1.2

10.20

24.24

u/l

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

456

0.79

0.71

1.1

1.16

3.57

eliau/ml

2.79

202

(3023323) Follitropin [Units/volume] in Serum or Plasma

170

1532

1.11

0.69

1.4

30.98

33.46

iu/l

0.40

143

1324

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

110

1.46

0.68

1.1

—

(1002224) Polysomnography panel

180

1631

1.11

0.67

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

109

958

1.14

0.67

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.63

0.66

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.59

0.65

1.0

1.1

0.02

0.03

u/ml

—

(4212803) Bone marrow aspirate examination

1.73

0.64

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

259

2397

1.09

0.63

2.6

2.4

13.61

13.27

nmol/l

0.24

234

2167

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3276

32500

1.07

0.63

5.7

5.2

1.44

1.50

mmol/l

12.26

3084

30173

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

155

1.36

0.63

1.2

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

302

0.76

0.62

1.3

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.59

0.61

1.9

1.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.67

0.61

1.0

1.2

8.62

6.13

mmol/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

226

1.29

0.61

2.3

1.9

6.04

6.47

umol/l

0.07

159

(3005322) IgE [Units/volume] in Serum or Plasma

250

2317

1.08

0.60

1.4

1.3

222.19

195.29

u/ml

0.26

234

2145

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.21

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

218

1.29

0.60

1.3

1.2

81.05

79.03

u/l

0.09

191

(21494890) Protein electrophoresis panel - 24 hour Urine

344

1.22

0.59

1.7

2.1

—

(40768795) Lymph node Pathology biopsy report

366

0.79

0.59

1.2

—

(3017181) Myelocytes/Leukocytes in Blood

339

3186

1.07

0.57

3.7

4.5

1.11

0.93

0.50

110

930

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

196

0.71

0.57

1.7

2.7

42.29

42.35

—

105

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.67

0.56

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.58

0.54

1.2

0.03

12.94

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.49

0.53

1.2

1.0

36.97

40.20

iu/ml

0.07

(3023199) Leukocytes [#/volume] in Pleural fluid

414

1.19

0.53

1.2

1.4

9761.00

4319.48

e6/l

0.31

288

(3044927) Protein electrophoresis panel - Urine

341

1.20

0.52

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

131

1188

1.11

0.52

3.1

3.9

81.77

96.97

mg/l

0.10

110

1022

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

305

1.22

0.51

1.1

1.2

102.05

110.46

pmol/l

0.59

305

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

214

0.75

0.51

2.1

1.4

—

74.12

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.46

0.50

1.0

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

235

1.24

0.48

1.3

1.1

5.12

8.61

iu/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

100

901

1.11

0.46

1.9

1.6

20512.20

11606.63

e6/l

0.65

616

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

165

0.73

0.46

9.7

13.7

893.25

8798.70

nmol/l

0.49

157

(3002179) Metamyelocytes/Leukocytes in Blood

323

3059

1.06

0.46

3.7

4.3

0.81

0.73

0.21

103

890

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

129

1.32

0.45

1.1

—

(4035726) Immunohistochemistry procedure

309

3263

0.94

0.45

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

130

1190

1.10

0.45

3.1

3.9

35.50

59.51

mg/l

1.05

111

1027

(3003434) Protein [Mass/volume] in Pleural fluid

459

1.16

0.45

1.2

1.5

33.59

32.72

g/l

0.18

417

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.40

0.45

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.40

0.45

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.40

0.45

1.0

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

220

0.77

0.44

1.1

18.94

17.98

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

231

0.78

0.44

5.7

7.0

2.24

157.67

ug/l

—

150

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

311

1.19

0.44

1.1

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

758

7346

1.04

0.43

4.5

22.55

21.71

0.82

377

3648

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

266

1.20

0.43

2.1

1.9

1.11

1.49

u/field

0.44

148

(3006922) Hepatitis E virus Ab [Presence] in Serum

257

1.21

0.43

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

755

0.89

0.43

3.3

56.73

57.59

0.24

755

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1465

14933

0.97

0.42

2.0

1.9

1.41

1.37

mmol/l

0.88

1254

12450

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

212

1.23

0.42

1.5

4.25

7.09

u/l

1.18

181

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

212

1.23

0.42

1.3

1.2

14.45

20.96

u/l

0.77

180

(3037756) Immunofixation for Serum or Plasma

718

1.12

0.41

1.4

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

118

1286

0.91

0.41

1.3

1.4

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

1.86

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.41

0.0

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.11

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.40

0.0

1.0

—

0.18

—

(40758292) HTLV I+II Ab panel - Serum

1.33

0.40

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

324

1.17

0.40

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

130

1199

1.09

0.40

1.8

1.7

3.20

4.41

mg/l

0.88

102

904

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.40

0.0

1.1

—

0.02

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.6

—

37.78

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.43

0.39

1.0

1.8

—

(40761536) Microorganisms panel - Urine sediment

254

2678

0.94

0.37

5.0

3.9

—

(40765096) Chromosome analysis panel by Banding

113

0.71

0.37

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.31

0.37

2.3

2.1

—

(3014051) Protein [Presence] in Urine by Test strip

985

9635

1.03

0.34

3.4

3.0

0.08

0.03

0.25

226

(3033099) Centromere Ab [Titer] in Serum

1.34

0.34

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

183

1728

1.06

0.32

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

210

1.19

0.32

1.9

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

367

3813

0.96

0.32

3.4

4.3

61.11

20.17

ug/l

0.47

315

3063

(3000034) Microalbumin [Mass/volume] in Urine

306

0.85

0.32

3.7

3.0

21.54

33.59

mg/l

0.49

225

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.33

0.32

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

202

1.19

0.31

1.4

1.7

2.36

4.48

ug/l

0.78

154

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

156

1.22

0.31

1.1

1.0

—

(3021440) Promyelocytes/Leukocytes in Blood

317

3046

1.04

0.30

3.8

4.6

0.12

0.05

792

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

125

1333

0.94

0.29

2.5

3.6

468.38

2113.49

u/ml

1.07

109

1140

(40757373) Influenza virus identified in Isolate

1.23

0.29

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

216

0.83

0.28

1.7

1.6

—

(3018133) Calcium [Moles/volume] in Urine

1.25

0.27

2.0

2.09

3.27

mmol/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

480

0.89

0.27

1.1

0.46

1.25

u/ml

1.40

226

(4211845) Urine protein measurement

150

0.80

0.27

4.3

3.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

111

1040

1.07

0.27

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

281

1.14

0.26

1.6

1.3

0.32

0.96

u/ml

1.00

158

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

104

1.25

0.26

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

171

0.82

0.26

15.7

17.8

1396.21

1467.89

nmol/l

0.10

166

(3038177) Helicobacter pylori Ab [Presence] in Serum

530

1.10

0.25

1.2

—

(4146454) Self-monitoring of blood glucose

382

0.89

0.24

3.2

2.6

—

(3012441) Differential panel - Pleural fluid

340

1.12

0.24

1.2

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

369

1.11

0.24

1.2

50.34

55.39

u/l

0.43

335

(3002619) Bacteria identified in Specimen by Culture

1.28

0.24

1.0

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

111

1046

1.06

0.24

3.1

3.6

3.01

3.47

ratio

0.14

604

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

233

0.86

0.23

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

360

1.11

0.23

1.2

1.4

42439.00

87808.82

e6/l

0.60

193

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.32

0.23

1.4

—

(3006462) Nitrate [Presence] in Urine

136

0.81

0.23

4.5

3.6

—

(3025130) Human papilloma virus identified in Specimen

524

1.09

0.23

1.7

1.8

—

(40768443) Skin Pathology biopsy report

169

1615

1.05

0.23

1.2

—

(3010813) Leukocytes [#/volume] in Blood

3539

35309

1.04

0.22

33.4

24.2

6.91

6.63

e9/l

10.86

3493

34487

(3011412) CD3 cells [#/volume] in Blood

314

1.12

0.22

2.4

2.3

1245.00

1119.58

e6/l

0.33

281

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

30.90

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.73

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.24

0.21

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

437

0.91

0.19

1.1

2.65

2.82

u/ml

0.04

199

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

520

1.08

0.19

1.1

76.82

1180.42

iu/ml

0.50

113

(3028717) Thiamine [Mass/volume] in Blood

1.13

0.18

1.2

1.3

76.00

67.08

ug/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

947

9600

0.98

0.18

3.8

3.4

1.07

0.21

estimate

0.50

302

2923

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

109

1.19

0.18

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

109

1.19

0.18

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

109

1.19

0.18

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

109

1.19

0.18

1.3

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

206

0.87

0.18

1.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.19

0.18

1.7

10.57

45.23

pmol/l

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

204

1.13

0.18

2.9

2.5

0.83

0.68

e9/l

0.48

197

(21494814) CD8 cells/Lymphocytes in Specimen

153

0.85

0.18

1.9

1.8

30.77

29.35

0.10

153

(3007461) Platelets [#/volume] in Blood

3537

35302

1.04

0.18

33.4

24.2

253.70

252.82

e9/l

0.34

3494

34608

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3537

35305

1.03

0.17

33.3

24.1

91.64

91.31

4.55

3510

34942

(3026470) Cobalt [Mass/volume] in Blood

194

0.88

0.16

2.9

2.1

12.30

3.37

ug/l

0.61

182

(3035941) MCH [Entitic mass]

3537

35306

1.03

0.16

33.2

24.0

30.47

30.36

3.67

3510

34942

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

573

1.07

0.16

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.14

0.16

1.3

2.4

155.50

54.00

ug/l

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3537

35308

1.03

0.16

34.1

24.5

39.84

40.45

4.36

3510

34928

(3036071) Salmonella sp Ab [Titer] in Serum

111

1.17

0.15

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

111

1.17

0.15

2.1

1.7

800.40

21108.48

e6/l

—

(3025159) Blasts/Leukocytes in Blood

316

3087

1.03

0.15

4.1

4.7

0.10

0.19

0.35

756

(3026361) Erythrocytes [#/volume] in Blood

3537

35309

1.03

0.15

33.3

24.1

4.40

4.47

e12/l

17.81

3491

34492

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.76

0.15

1.2

1.5

1.12

1.18

mmol/l

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

565

1.06

0.15

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.14

0.15

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

417

4249

0.98

0.14

5.5

5.0

32.19

32.40

0.14

304

2729

(3016228) CD19 cells/cells in Blood

150

0.87

0.14

1.9

1.8

5.85

7.59

0.39

145

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

547

1.06

0.14

1.1

11.24

19.17

au/ml

0.62

135

(3003329) Lymphocytes/Leukocytes in Synovial fluid

304

1.09

0.14

1.4

1.5

25.02

34.47

0.85

179

(3023487) Leukocytes [#/volume] in Peritoneal fluid

131

1.15

0.14

2.0

3473.38

700.30

e6/l

—

(3000963) Hemoglobin [Mass/volume] in Blood

3537

35314

1.03

0.14

33.6

24.3

132.90

134.92

g/l

14.24

3511

34961

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

634

0.95

0.14

1.1

2.39

1.62

u/ml

0.21

341

(3045683) HLA typing for celiac disease panel - Blood or Tissue

189

1.11

0.13

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

113

1.15

0.13

1.4

1.5

9.21

8.86

ug/l

0.14

113

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.17

0.13

6.6

2.7

5.47

4.85

kpa

1.11

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.17

0.13

6.6

2.7

9.14

10.30

kpa

0.96

(3023430) Cat dander IgE Ab [Units/volume] in Serum

406

0.94

0.12

1.1

2.79

2.92

u/ml

0.02

164

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

845

1.04

0.12

1.1

5.58

7.22

eliau/ml

—

101

(3001186) Copper [Moles/volume] in Serum or Plasma

104

1.15

0.12

1.4

1.2

16.43

16.68

umol/l

0.12

(3025018) Bordetella pertussis Ab [Titer] in Serum

229

1.09

0.12

1.5

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

753

0.96

0.12

2.6

2.2

95.97

108.63

ug/min

0.10

442

(3041354) Potassium [Moles/volume] in Venous blood

346

1.07

0.12

2.2

2.3

3.96

4.04

mmol/l

0.95

340

(3035285) Chloride [Moles/volume] in Venous blood

346

1.07

0.12

2.2

2.3

105.97

105.20

mmol/l

0.61

340

(3021589) Normoblasts [#/volume] in Blood

1527

15172

1.01

0.11

13.1

11.5

0.00

e9/l

1.52

1252

12381

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

136

0.88

0.11

3.1

3.5

1.75

1.35

0.46

136

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

260

0.92

0.11

1.2

1.3

—

(3004451) EKG impression Narrative

192

1.09

0.10

1.4

1.3

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

156

0.90

0.10

1.0

1.2

8.50

10.28

mm/h

0.58

156

(3005011) Chlamydia sp Ab [Titer] in Serum

1.11

0.09

1.4

1.5

—

(3044941) Cell count panel - Synovial fluid

654

1.04

0.09

1.6

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

124

0.89

0.09

1.6

1.8

1.88

1.83

ratio

0.04

119

(21494434) Karyotype in Bone marrow

311

1.06

0.09

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.11

0.09

1.3

1.4

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.09

0.08

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

451

0.95

0.08

1.6

—

(40768441) Liver Pathology biopsy report

273

1.06

0.08

1.6

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

549

1.04

0.08

1.1

—

(36660697) Celiac disease serology panel - Serum

279

2753

1.01

0.07

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

550

1.04

0.07

1.1

—

(3045142) Bone marrow Pathology biopsy report

418

0.96

0.07

1.4

—

(3000012) Reticulocyte production index

491

1.04

0.07

1.6

2.2

0.91

0.90

0.02

318

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

909

9140

0.99

0.06

5.1

5.5

2.13

2.73

ug/l

2.75

846

8297

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

292

2887

1.01

0.06

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

294

0.95

0.06

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

247

1.05

0.05

1.7

1.5

30.20

21.67

u/ml

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

159

1.07

0.05

3.8

4.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

686

1.02

0.04

2.1

1.9

0.98

0.84

nmol/l

1.13

584

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

369

1.03

0.03

1.1

0.09

0.15

u/ml

—

121

(3024263) Appearance of Synovial fluid

179

0.95

0.03

1.1

1.7

—

(40768806) Pleura Pathology biopsy report

340

1.03

0.03

1.5

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

229

0.96

0.02

1.8

1.6

79.14

79.45

umol/l

0.03

229

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

249

0.96

0.02

1.7

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

198

0.96

0.02

1.5

174.89

207.29

pmol/l

0.28

198

(3020491) Glucose [Moles/volume] in Blood

228

0.96

0.02

1.4

1.7

5.85

6.85

mmol/l

1.94

144

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

278

0.97

0.02

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

508

0.98

0.01

1.1

0.52

1.10

u/ml

0.94

206

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

164

1.04

0.00

1.2

1.3

5.84

6.02

mmol/l

0.29

157

(3033705) Calcium.ionized [Moles/volume] in Venous blood

338

1.01

0.00

2.3

1.21

1.20

mmol/l

0.39

332

(3020876) Protein [Mass/time] in 24 hour Urine

422

1.00

0.00

2.0

2.4

1.23

1.22

g/24h

0.01

238

(3017704) Immunofixation for Urine

195

0.97

0.00

1.3

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

521

1.00

0.00

1.1

2.33

3.00

u/ml

0.38

252

(3042111) Morphology [Interpretation] in Bone marrow Narrative

601

1.00

0.00

1.7

—

(3010503) CD19 cells [#/volume] in Blood

216

1.02

0.00

2.9

2.4

154.32

123.90

e6/l

0.32

210

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

104

0.96

0.00

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

436

1.01

0.00

1.1

—

(3047189) Immunofixation for 24 hour Urine

164

0.98

0.00

1.1

1.8

—

(3044007) Cell count panel - Peritoneal fluid

116

1.03

0.00

1.5

1.8

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.7

—

0.25

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.8

—

8.50

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.03

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

1.62

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.98

-0.00

1.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1270.00

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3521.80

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

160

1.00

-0.00

1.2

1.7

41.16

40.02

g/l

0.41

160

(3024869) Neuronal Ab [Presence] in Serum

1.02

-0.00

1.6

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.4

—

4.70

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.0

—

6.40

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

2.39

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.96

-0.00

1.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

340

1.00

-0.00

4.1

5.6

421.26

68.25

u/ml

—

103

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.96

-0.00

1.3

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

0.93

-0.00

1.0

1.5

17.71

24.03

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.93

-0.00

1.1

1.3

—

149.20

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.6

—

35.46

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.98

-0.00

1.4

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_ANEURYSM and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_ANEURYSM	2.021 [1.8, 2.27]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.366

During the follow-up period (1.1.1998 — 31.12.2019), 1412 out of 8126 females with I9_ANEURYSM died.

Males

Parameter	HR [95% CI]	p-value
I9_ANEURYSM	1.977 [1.76, 2.22]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.018

During the follow-up period (1.1.1998 — 31.12.2019), 1268 out of 5324 males with I9_ANEURYSM died.

Mortality risk

Mortality risk for people of age

years, who have I9_ANEURYSM.

N-year risk	Females	Males
1	0.174%	0.347%
5	1.132%	2.357%
10	3.003%	6.196%
15	5.76%	11.634%
20	9.92%	19.211%

Relationships between endpoints

↥

Index endpoint: I9_ANEURYSM – Cerebral aneurysm, nonruptured

GWS hits: 9

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cerebral aneurysm, nonruptured

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints